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Isotope Harvesting at Heavy-Ion Fragmentation Facilities 
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Washington University in St. Louis, 2014 
Dr. Suzanne E. Lapi, Co-Chair 
Dr. Lee G. Sobotka, Co-Chair 
 
 Isotope harvesting from heavy-ion fragmentation facilities is a potential source of 
isotopes of interest for applications research.  With the upgrade of the National Superconducting 
Cyclotron Laboratory (NSCL) to the Facility for Rare Isotope Beams (FRIB) usable quantities of 
many isotopes of interest will be produced and available for harvest from an aqueous beam 
dump.  If available, these isotopes would be of interest to a broad range of applications such as 
medicine, geology, and stockpile stewardship.  Preliminary experiments were performed at the 
NSCL in order to determine the feasibility of isotope harvesting at (FRIB). 
 A water target station that consisted of a 100 mL beam dump was designed and built to 
collect secondary beams at the NSCL.  This target station could be controlled remotely from 
outside of the experimental vault allowing for multiple collections with minimal exposure to 
radioactivity.  Three secondary beam collections were made with the water target station:  a 24Na 
beam, an analyzed 67Cu beam, and an unanalyzed 67Cu beam. 
x 
 
 To test the durability of the target station, a 73% pure 85 MeV/u 24Na secondary beam 
was stopped and collected in the beam dump.  Multiple collections were made with currents up 
to 2 x 106 particles per second without visible radiolytic damage to the target cell.  The station 
operated without any observed release of radiolytic gases, spills, or loss of radioactive liquids.  
 The water target station was then used collect a 77% pure 76 MeV/u 67Cu secondary 
beam.  67Cu was separated from the other secondary beam contaminants with an average 
recovery of 88 ± 3 % and used to radiolabel an antibody.  The radiochemical yield of 67Cu-
NOTA-Bz-NCS-Trastuzumab was >95%.    
 To better mimic the conditions that would be present in the beam dump at FRIB an 
unanalyzed beam was collected.  This secondary beam was 2.6% pure and contained many 
contaminants most of which are located in period four of the periodic table.  67Cu was separated 
from the beam contaminants with an average recovery of 74 ± 4% and a radiochemical purity of 
>99%.  The purified 67Cu was then used to radiolabel NOTA conjugated Panitumumab 
antibodies and injected into HCT-116 tumor bearing mice via tail vein injection.  A five day 
biodistribution profile was obtained and the tumor uptake of 67Cu-NOTA-Bz-NCS-Panitumumab 
was measured to be 12.5 ± 0.7 % ID/g. 
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Introduction 
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Nuclear Chemistry and its Applications in Medicine 
 Radioisotopes have been very important for the advancement of cancer imaging and 
treatment.  Single Photon Emission Computed Tomography (SPECT) and Positron Emission 
Tomography (PET), which detect administered radiotracers in the body, have become routine 
imaging modalities in cancer assessment.1-3  Additionally, advancements in radiotherapy now 
involve targeting cancers with therapeutic radioisotopes so that the radiation treatment is 
delivered directly to the tumor, reducing radioactive exposure to healthy cells.7,8  The nuclear 
properties, availability, and chemistry of the radioisotopes all have to be considered when 
designing tracers for the above techniques.   
 
Nuclear Chemistry 
Nuclear Decay (β+, β-, and γ) 
 The chart of the nuclides, a map of all known nuclei with the number of protons (Z) 
displayed on the ordinate and neutron number (N) on the abscissa, is shown in Figure 1-1.  
Understanding of this playfield of nuclear science requires understanding a suppressed third axis 
– mass. The minimum mass as a function of mass number, A= Z+N, forms a mass valley 
populated by the stable isotopes.  Isobars (A = constant) not at the bottom of the valley are on the 
(mass) valley walls and beta decay (via the isobar conserving weak interaction) to the stable 
nuclei at the valley bottom.  Isotopes on the left side of stability (North-West on the diagonal 
isobar) are proton rich and decay by electron capture (ε) and/or positron emission (β+).  Isotopes 
on the right side of stability (South-East) are neutron rich and decay by electron emission (β-).   
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Positron emission happens when a proton within the nucleus (indicated by the quotes in 
Equation (1)) of an atom is converted into a neutron by the emission of a positron and a neutrino 
(Equation 1) thus keeping the mass number the same and decreasing the atomic number by 1.  
An example of an isotope that undergoes positron decay is 18F (Equation 2).  The emitted 
positron thermalizes by electrostatic interactions with electrons, typically traveling 1-3mm 
before annihilating with an electron creating two 511 keV photons travelling at approximately 
180º from each other (Figure 1-2).  The Q-value makes the equations energy balanced and is the 
energy equivalent of the mass difference of the left and right sides of the arrow.  For positron 
decay to occur, the atomic mass difference must be at least 1.022 MeV otherwise the decay will 
occur via electron capture which is discussed below.  Note that the Q-value has the opposite sign  
 
Figure 1-1.  Chart of the Nuclides.4 
“p”       “n” + β+ + ν + Q        (1) 
 
 18F       18O- + β+ + ν + Q        (2) 
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convention as reaction enthalpies and is always provided on a unit basis rather than per mole of 
conversions.  In spontaneous decays, the Q-value is always positive.  Electron capture, which 
competes with positron decay, converts a proton into a neutron by capturing an inner-shell 
electron (Equation 3) also keeping the mass number the same, decreasing the atomic number by 
1 and emitting a neutrino.  An example of an isotope that undergoes electron capture is 49V 
(Equation 4).   
β- decay occurs when a neutron within the nucleus of an atom is converted into a proton 
by the emission of an electron and an antineutrino (Equation 5) thus keeping the mass number 
the same and increasing the atomic number by 1.  As the neutron is more massive than the proton 
plus an electron, the decay represented in Equation 5 without the quotes does occur 
 
Figure 1-2.  Positron decay and the resulting annihilation with an electron creating two 511 
keV gamma rays approximately 180º apart. 
“p” + e-        “n” + ν + Q         (3) 
 
 49V+ + e-        49Ti + ν + Q         (4) 
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spontaneously with a Qn = 0.78 MeV.  An example of an isotope relevant for medicine that 
undergoes β- decay is 99Mo (Equation 6). 
When isotopes undergo the different types of β decay, they often decay to an excited state 
in the daughter nucleus.  When this happens the nucleus decays to the ground state by the 
emission of one or several photons of discrete energy (γ decay) or by the emission of an orbital 
electron, which is called an internal-conversion electron.10  This is the case in the above decay in 
Equation 6 where 99Mo decays to an excited state in 99Tc, 99mTc, which after emission of an 
internal-conversion electron, with a kinetic energy of 2.2 keV minus the binding energy of the 
electron thereby decaying to another excited state in 99Tc, then decays to the ground state, 99gTc, 
usually by emitting a 140.5 keV gamma ray.  The atomic and mass numbers (Z and A) of the 
decaying atom remains unchanged in γ decay.   
 The decay properties for a specific radioisotope can be shown through a decay scheme.  
Decay schemes provide information on the type of decay, branching ratios to the different energy 
levels in the daughter nucleus, and the intensity and occurrence of the gamma rays from the 
 
Figure 1-3. The 137Cs decay scheme.4  In this case, photon emission from the state populated 
95% of the time in beta decay, decays to the ground state 85.1% of the time by the emission 
of a photon, the remainder of the deexcitations within the daughter 137Ba are by the internal-
conversion process. 
“n”         “p” + β- + ν +Q        (5) 
 
99Mo        99mTc + β- + ν + Q           (6) 
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excited states, populated by the beta decay of the parent atom, to the ground state of the 
daughter.10,11  An example decay scheme is shown for 137Cs in Figure 1-3.4     
 
Positron Emission Tomography (PET) 
  Positron Emission Tomography (PET) is a common imaging modality used for 
diagnostic imaging in oncology, cardiology and neurology.  PET takes advantage of the 
approximate collinearity of the annihilation photons resulting from β+ decay.  In a PET scanner, 
scintillation crystals are positioned in a ring around the patient.  The event is detected through 
the coincidence detection of the two 511keV photons that are detected at the same time and 
across the ring.  Algorithms are then used to reconstruct an image from the intersection of the 
lines from different decays (Figure 1-4). 
The two main factors that limit the resolution of this method are non-collinearity, 
resulting from non-zero momentum from the positron-electron pair before the annihilation, and 
that the annihilation point is remote from that of the original radioactive decay.  Since β+ decay is 
a three-body final state as shown in Equations (1) and (2), the energy of an emitted positron is 
not discrete but rather a spectrum of energies.  The positron energy distribution is therefore 
usually characterized by either E(β+mean) or E(β+max) with the mean positron energy about one 
third of the maximum energy for light nuclei.  The E(β+max) limits the resolution of this imaging 
modality because higher energy positrons travel further in the tissue before reaching thermal 
energies where the probability of annihilation with an e- is maximal.  Algorithms have been 
created to decrease the effect from these factors and improve the overall resolution.12,13 
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The most common PET radiopharmaceutical is [18F]FDG (2-[18F]Fluoro-2-deoxyglucose) 
(Figure 1-5 A) and has been used in cancer detection for more than twenty-five years.14  As a 
glucose derivative [18F]FDG’s mechanism of action is through the glycolytic pathway.  Unlike 
glucose (Figure 1-5 B), once [18F]FDG is taken up by the cells and converted into 2-[18F]fluoro-
2-deoxyglucose-6-phosphate it cannot undergo further catabolism due to the lack of oxygen at 
the C-2 carbon thus it becomes trapped inside the cell.14,15  Due to the high glycolytic rate of 
 
Figure 1-4.  Schematic of Positron Emission Tomography (PET). 
 
Figure 1-5.  Structures of A 2-[18F]Fluoro-2-deoxyglucose and B Glucose.  The C-2 carbon 
(counting from the internal ether O) is bonded to the positron emitting radionuclide 18F. 
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cancer cells, [18F]FDG accumulation is typically higher in cancer cells than normal cells which 
makes it an optimal imaging agent for cancer detection based on metabolic function.          
Single Photon Emission Computed Tomography (SPECT)        
 Single Photon Emission Computed Tomography (SPECT) is the most common nuclear 
medicine imaging modality.  Radionuclides that are good for SPECT imaging typically decay 
with the emission of a low-energy gamma ray (~140 keV).  In SPECT imaging one or more 
scintillation cameras rotate around the patient taking multiple two-dimensional projections that 
are then compiled to make a three-dimensional image with the use of algorithms taking 
advantage of the isotropic emission pattern of γ rays from nuclei existing under normal 
conditions (e.g. not employing ultra-low T and high magnetic fields) (Figure 1-6).  
 
Figure 1-6.  Schematic of Single Photon Emission Computed Tomography (SPECT). 
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A limitation of SPECT imaging is the need for collimators in order to determine the angle 
of incidence.  These collimators reject photons that are outside a very small angular window.  
Because of this limitation, a larger amount of activity must be injected in order to achieve an 
image which is a major disadvantage as compared to the higher sensitivity of PET imaging.12,13   
 99mTc is the most widely used radionuclide in nuclear medicine and SPECT imaging has 
been optimized to accommodate the 140.5 keV gamma ray resulting from the decay of 99mTc as 
described earlier.  One of the most common scans involving 99mTc is a bone scan which employs 
the radiopharmaceutical 99mTc-diphosphonate.  Increased 99mTc-diphosphonate uptake can 
signify diseases such as certain types of bone metastases, osteomyelitis and arthritis, where 
decreased uptake signifies lytic lesions or tumor necrosis.16  
 
Properties of Important Isotopes Presented in this Work 
 The isotopes and their decay properties discussed in this work are listed in Table 1.  64Cu, 
68Ga, and 55Co were made at Washington University School of Medicine.17  24Na and 67Cu were 
obtained from the National Superconducting Cyclotron Laboratory (NSCL) at Michigan State 
University.18  The remaining isotopes listed in the table are side products.   
Table 1-1.  Properties of isotopes discussed  
Isotope Half-Life Decay βmax(MeV) Associated Gammas (keV) 
24Na 14.97h β- 1.39 1369, 2754 
55Co 17.53h β+ (76%), ε (24%) 1.50 931, 477, 1408 
57Co 271.8d ε (100%)  122, 136 
57Ni 35.6h β+ (43.6%), ε (56.4%) 0.865 1378, 127, 1919 
64Cu 12.7h β+ (17.6%), ε (43.9%),  
β- (38.5) 
β+(0.653), 
β-(0.579) 
1346 
67Cu 2.58d β- 0.562 185, 93.3, 91.3 
68Ga 1.13h β+ (88.9%), ε (11.1%) 1.90 1077 
Data was obtained from the National Nuclear Data Center, Brookhaven National Laboratory, 
Upton, NY.  Website:  http://www.nndc.bnl.gov/chart/chartNuc.jsp4 
Imaging and Therapeutic Applications of Radioisotopes 
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 As discussed above, the gamma rays emitted from the decaying atom (either from the 
nucleus or annihilation photons) can be used for PET or SPECT imaging depending on the type 
of decay.  In order to be useful for imaging, these isotopes need to be delivered to the target of 
interest, for example cancer cells.  This requires different chemistries to incorporate the 
radioisotope onto a targeting probe (i.e. small molecules, antibodies, peptides, or nanoparticles).  
For radiometals this can be achieved by conjugating the probe with a chelate that has a high 
affinity for the isotope of interest.  In this work we will discuss two chelators with high affinity 
for copper and cobalt. 
 In addition to imaging, radioactive decay can be employed for use in cancer therapy.  β- 
particles are of considerable interest for cancer therapy due to the increased linear energy transfer 
(LET) to the tissue being irradiated compared to gamma irradiation.  Positrons have similar 
linear energy transfer to β-, however this decay mode is not of interest for therapy for two 
reasons: the accompanying 511 keV gamma rays and the competition with electron capture.  
Beta particles travel about 1-3 mm in tissue effectively depositing all of their energy in a small 
distance causing damage to the nearby cells.  To achieve this therapeutic effect, the radioisotopes 
must be delivered very close to the targeted tissue.  An example of a therapeutic isotope often 
used in medicine is 90Y with Q = 2.28 MeV, average β- energy of 0.937 MeV, and an average 
range of 2.5mm in tissue.19,20     
 
Antibodies for use in Cancer Imaging and Therapy 
 One class of molecular probes used for both cancer imaging and therapy is antibodies.  
Antibodies by themselves can be therapeutic and several are FDA approved for therapy.21  
Radiolabeling these antibodies with a therapeutic isotope can increase the therapeutic dose 
11 
 
delivered to the target tissue.22-24  The incorporation of radiometal isotopes onto the antibody of 
interest is typically achieved by the use of chelators that are conjugated onto the antibody.  Two 
popular chelates conjugated onto antibodies for radiometal incorporation are DOTA (1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetraacetic acid) and NOTA (1,4,7-triazacyclononane-N,N',N"-
triacetic acid) (Figure 1-7A, B).  The conjugation is typically achieved through an NCS group   
that is incorporated onto the chelate.  The NCS group reacts with exposed lysine groups on the 
antibody (Figure 1-7C).  Both NOTA and DOTA chelates can be used to incorporate radioactive 
copper and cobalt atoms, however, NOTA has been shown to lead to more stable copper 
conjugates than DOTA.25,26    
 Once an antibody is radiolabeled it can be injected into tumor bearing mice for preclinical 
studies or into patients for clinical assessment. Following this, tumor accumulation can be 
 
Figure 1-7.  A DOTA-bz-NCS, B NOTA-bz-NCS, and C Conjugation of DOTA-bz-NCS to 
lysine residue on an antibody (Y). 
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determined through imaging (both preclinical and clinical) and/or biodistribution (preclinical, 
Figure 1-8).  Tumor imaging using PET or SPECT gives a picture of where the radioisotope 
goes in the body and helps determine the time at which the best tumor to non-target contrast can 
be achieved.  Standard uptake values (SUV) are used to quantify the amount of the radioisotope 
that was delivered to the tumor or other non-target organs by taking the activity measured 
through PET or SPECT imaging and dividing by the total injected dose per body weight.  
Biodistribution data is obtained by sacrificing the mice and performing a dissection to determine 
the radioactivity uptake by different organs.  This information is typically provided as %ID/g (% 
Injected Dose per gram).  With these two methods, radiotracers can be developed that lead to the 
highest tumor uptake with the smallest achievable dose to non-target tissues.  
 
Heavy Ion Fragmentation Facilities 
At several nuclear-physics research facilities, heavy-ion beams are generated and are 
used to bombard light element targets, like berylium or carbon, to produce secondary radioactive 
ion beams (usually by fragmentation reactions).  These secondary beams can be used to study 
nuclear reactions involving reactants outside of the beta-stable region (higher up on the mass 
 
Figure 1-8.  Purified radioisotope is added to a NOTA conjugated antibody to produce a 
radiopharmaceutical and that is then injected into tumor bearing mice.  After some 
predetermined amount of time (usually 3-5 days for antibodies) animals are sacrificed, 
dissected and their organs and tumors are measured for radioactivity. 
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valley walls as discussed earlier). These secondary reactions inform on the structure of nuclei 
with unusal n/p combinations, structure that, can dictate how elements are made in the first place 
- nucleosynthesis.  Typically the end user is interested in one radioactive ion that was produced 
in the first reaction and the other isotope products created go to waste.  Finding methods to 
“harvest” these unused isotopes is of considerable interest for applied research in medicine, 
stockpile stewardship, geology, and astrophysics. 
 
National Superconducting Cyclotron Laboratory 
 The National Superconducting Cyclotron Laboratory (NSCL) is a heavy-ion 
fragmentation facility located at Michigan State University (MSU).  Two cyclotrons in series, a 
K500 and a K1200, are used to accelerate heavy ions that are fragmented using a berylium target.  
(The K number is the collection of constants that, if there were no other limitations, would be the 
maximum proton energy.) An illustration of the fragmentation process is shown in Figure 1-9.  
After fragmentation, the isotopes are passed through the A1900 fragment separator27 which 
selects the isotope of interest to an end user by employing two pairs of dipole magnets with an 
interviening wedge absorber that reduces the energy of the ions differently depending on their 
atomic number. Several quadrupole focusing magnets are also employed in the A1900 to achieve 
 
Figure 1-9.  Illustration of heavy ion beam fragmentation.  Note that isotopes created are not 
separated in physical space and can only be separated in the A1900 by magnetic rigidity. 
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high transmission of the desired ion.  The secondary beam is then sent to one of many vaults for 
nuclear-physics research.  Figure 1-10 shows a schematic of the NSCL.  A code called LISE++ 
can be used to simulate the primary fragmentation reaction and to detemine the optimal 
parameters for the magnets and wedge absorber to select the desired beam with maximal purity 
and to assess the  contaminants in the beam.28   
 
Upgrade to the Facility for Rare Isotope Beams 
The NSCL is currently undergoing an upgrade to become the Facility for Rare Isotope 
Beams (FRIB) (Figure 1-11).  FRIB will replace the two cyclotrons currently in operation at the 
NSCL with a linear accelerator.  The new facility will be able to increase the energy of the 
heavy-ion beams available along with increasing the current by three orders of magnitude.29  
With the capability to fragment one thousand times more ions, an aqueous beam dump will be 
employed to collect the isotopes that are not wanted for the end user’s experiments.  This 
dramatically increases the potential for harvesting and has piqued the interest of several 
communities.   
 
Figure 1-10. Schematic of the NSCL located at Michigan State University9 
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Harvesting Isotopes of Interest from an Aqueous Beam Dump at FRIB 
 Many isotopes of interest will be available in usable quantities for harvest from the 
aqueous beam dump at FRIB.30  A committee of users from the isotope community was formed 
to generate an initial list of isotopes of interest for a large range of scientific applications (Table 
1-2).  As part of this thesis work, proof-of-principal experiments were performed in order to 
develop strategies for the online harvesting of isotopes from the aqueous beam dump at FRIB so 
that optimal accomodation for harvesting can be made during the construction of the new 
facility.  In order to perform these proof-of-principal experiments, a mock beam dump was 
designed and built to collect secondary radioisotope beams at the NSCL.  Additionally, 
separation strategies were developed to determine feasibility, purity, and efficiency of separating 
 
Figure 1-11.  Schematic of the Facility for Rare Isotope Beams at Michigan State University6 
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the isotopes of interest from the other activities in the aqueous beam dump.  Preliminary 
experiments designed to address some of these concepts will be discussed in this thesis. 
 
Table 1-2.  Isotopes of interest for isotope harvesting. 
Isotope Decay Mode Half-Life Application 
32
Si β
-
 162y Tracer; geology, botany 
44
Ti ε 59.2y Medicine, astrophysics, Nuclear Structure 
48
V β
+,ε
 15.98d Stockpile Stewardship, Medicine 
67
Cu β
-
 2.6d Medicine 
85
Kr β
-
 10.76y Astrophysics, Stockpile Stewardship 
147Eu-154Eu  24d-37y Stockpile Stewardship 
211
Rn α 14.6h Medicine 
225
Ra β
-
 14.9d Medicine, Electric Dipole Moment 
225
Ac α 10.0d Medicine 
 
 
Radioisotope Production Using Small Medical Cyclotrons 
The use of low-energy cyclotrons to produce isotopes at medical facilities has been 
increasing, largely due to the FDA approval of [18F]FDG as previously discussed.  These 
cyclotrons usually accelerate protons (some also accelerate deuterons and/or alpha particles) and 
typically range in proton energy from 11-30 MeV.  A cyclotron works by accelerating charged 
protons, for example H+ or H-, using an AC modulated electric field and a single large dipole 
magnet (schematic shown in Figure 1-12).  In the classical (as developed by E. Lawrence in the 
early 1930’s) cyclotron there are two dees in which the ions are shielded from the electric field 
when they travel through them.  Once a proton exits the inner edge of the dee it was traveling in, 
an accelerating electric field is sensed across the gap (between the dees) causing the proton to 
accelerate across the gap.10,31  The protons travel in a circular path characteristic of a charged 
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particle moving in a constant magnetic field, imposed by the dipole.  As the ions increase in 
speed, the circular path increases in diameter and a spiral trajectory results.  (One can view a 
cyclotron as a linear accelerator made efficient in space and energy by the reuse, on each turn, of 
the same set of accelerating gaps.  Higher energy cyclotrons often have 3 or more dees.)  The 
engineering of the acceleration scheme for a cyclotron is simple compared to the initiation and 
extraction aspects. The latter is made much easier by using H- rather than H+.  H- ions are 
accelerated through a thin carbon stipper foil, which strips the H- of its two electrons creating H+. 
This change in charge causes the path to arc outwards and be directed towards an external target 
for isotope production at an efficiency of nearly 100%.  H+ ions are deflected by use of an 
electrostatic channel that steers the ions out of the cyclotron often with an efficiency less than 
75%.  The beam that is lost using H+ deflection causes nuclear reactions making the internal 
cyclotron parts radioactive.11,32   
 
 
 
Figure 1-12.  Schematic of a cyclotron5 
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Nuclear Reactions (p,n) and (p,α) 
 Several proton induced nuclear reactions are attainable at low energies (11-30 MeV).  
During most low-energy nuclear reactions the proton combines with the target nucleus to create a 
compound nucleus.  This compound nucleus is highly excited and deexcites  by evaporating 
particles, usually neutrons but sometimes protons or alpha particles and even more rarely larger 
nuclei, and leaves behind a new isotope.  For example a 15MeV proton combines with a 58Ni 
atom forming a compound nucleus of 59Cu that then evaporates an alpha particle to become 55Co 
(Figure 1-13).  As in decay, the mass difference between reactants and products is the Q-value, 
but it can be of either sign for reactions. The Q-value is most conveniently calculated by 
subtracting the mass excess, Δ = (Actual mass in atomic mass units – A)*c2,  of the products 
from the reactants (Equation 7).  (Mass excesses can be used as neither neutrons nor protons are 
being created, they are just being rearranged – this is no different than a reaction enthalpy where 
the masses of the atoms do not need to be considered as they just redistributed).  The Q-value for 
the reaction above creating 55Co is -1.33 MeV.  This sign means that the mass of the products is 
more than that of the reactants thus there is an absolute minimum proton energy below which the 
reaction probability is zero.   
 
Figure 1-13.  Illustration of the nuclear reaction 58Ni(p,α)55Co. 
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Another important factor to consider in reactions between charged particles is the 
Coloumb barrier.  Because the proton and the target atom are both positively charged, the proton 
must overcome the Coulomb barrier (VC) approximately given by Equation 8 where Z1 is the 
atomic number of the incoming atom (1 for proton initiated reactions), Z2 is the atomic number 
of the target nucleus, and R1 and R2 are the radii of the incoming and target nuclei respectively.  
In Equation 8, VC is in MeV when R is in fm.
10,11  The larger the Coulomb barrier, the more 
energy must be provided for the reaction to occur with significant probability.  The energy 
required to overcome the Coulomb barrier for 58Ni(p,α)55Co is 5.52 MeV.  The threshold energy 
of the reaction (the amount of energy required for the reaction to occur) is the higher of the two 
energies: the negative of the Q-value (a thermodynamic threshold) and the Coulomb barrier (a 
kinetic threshold).  
The probability of a nuclear reaction occuring is called a cross section, a quantity with the 
dimensions of area.  Typically the units are given in millibarns where 1 millibarn = 1 x 10-27cm2.  
Plotting the cross section vs incident particle energy yields an excitation function (Figure 1-14).   
This functional dependence along with the thickness of the target can be used to estimate the 
yield of a reaction (Equation 9) where R is rate per second, N is the number of target atoms per 
cm2, σ is the cross section in cm2, and ϕ is the particle flux, which in this case is the number of 
protons per second.  If the target is sufficiently thick so that the energy of the projectile drops as 
it proceeds though the target, the yield can be estimated summing (or integrating) the rate over 
an imagined stack of (L) thin targets each with Ni  atoms per unit area and a cross section σi 
appropriate to the energy of the projectile when it arrives at that target slice.  For bombardments 
VC = 
𝟏.𝟒𝟒∗𝒁𝟏∗𝒁𝟐
𝑹𝟏+𝑹𝟐
          (8) 
p + A       α + B  or A(p,α)B with     Q = Δp + ΔA - Δα – ΔB (7) 
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that are long compared to the half-life of the isotope being produced, saturation is achieved 
resulting from the decay rate of the produced radioactivity rising to match the production rate.  In 
the work presented here I will discuss the use of small medical cyclotrons to produce 55Co via 
the 58Ni(p,α)55Co reaction.   
 
This thesis will discuss the first attempts and “proof of concept” experiments for isotope 
harvesting.  In Chapter 2 a measurement will be presented that was useful for the development of 
separation strategies for the harvesting of 67Cu and to measure the final purity of 55Co 
productions.  Chapter 3 will address the design of an end station for use at the end of a beam line 
at the NSCL to collect isotopes in water.  This end station was tested and validated using a 
purified 24Na beam.  Chapter 4 presents the collection of a mostly pure 67Cu beam and its 
subsequent separation and use for antibody labelling.  Chapter 5 expands on Chapter 4 by testing 
the separation strategy using a no wedge beam (this means that the beam was not subjected to the 
majority of the magnetic separation in the A1900) thus it contained many contaminants.  This 
 R = Nσϕ = ∑ (𝑵𝒊𝝈𝒊𝝓
𝑳
𝒊=𝟏 )                   (9) 
 
Figure 1-14.  Excitation functions for the 58Ni(p,α)55Co reaction.4 
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chapter also presents the separation, purification and the radiolabelling of an antibody with 67Cu 
followed by injection into tumor-bearing mice, and the resulting 5-day biodistribution.  Chapter 
6 consists of a side project, the production of 55Co via the 58Ni(p,α)55Co reaction, looking at free 
55CoCl2 (not chelated) in tumor bearing mice and the resulting biodistribution at 24 and 48 hrs, 
along with labeling DOTA or NOTA conjugated peptides in order to determine the stability of 
55Co in DOTA and NOTA complexes in vivo.  Conclusions and thoughts on future work are 
presented in Chapter 7.  
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Specific Activity Measurement of 64Cu:  
A Comparison of Methods 
[This work has been published previously as Tara Mastren, James Guthrie, Paul Eisenbeis, Tom 
Voller, Efrem Mebrahtu, J. David Robertson, and Suzanne E. Lapi, Applied Radiation and 
Isotopes. 2014, 90, 117-121] 
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Introduction 
 Specific activity is a measurement of the purity of a radioisotope.  Effective specific 
activity (ESA) is the amount of radioactivity per unit mass of competing metal for a certain 
chemical or biological reaction.  True specific activity is the amount of radioactivity per μmol of 
atoms of the same element (for example amount of 64Cu per μmol total copper).  Theoretical 
maximum specific activity is the amount of radioactivity per μmol of the radioactive species (for 
example radioactivity of 64Cu per μmol 64Cu).  The theoretical maximum specific activity for 
64Cu, a common radiometal used in preclinical and clinical research, is 2.47 x 105 mCi/μmol.   
 The specific activity of a given radionuclide is important in developing the chemistry for 
labelling compounds.  Typically it is desired to have as close to the theoretical maximum specific 
activity as is reasonably achievable.  In radiometal productions many efforts are in place to 
reduce the amount of contaminating metals present.  Trace metal grade chemicals are used in 
various cleaning and manufacturing steps and all glassware and materials that come into contact 
with the radioactivity are washed in a nitric bath for 24 hours to remove surface metal 
contaminants.  Additionally, separation chemistries to isolate the radiometal of interest from the 
target material are optimized to improve the final purity.  
There is a growing demand for 64Cu for use in Positron Emission Tomography (PET) 
research.  A review of the literature shows that the number of publications involving 64Cu has 
more than tripled since 2000.  The 12.7 hr half-life and the low beta energy of 64Cu (Eavg = 0.278 
MeV) makes it an optimal PET isotope for imaging up to 48 hours after administration (Figure 
2-1).  Similarly these properties of 64Cu make it an ideal candidate for labeling peptides and 
antibodies as the time required for these tracers to accumulate in the target organs (a few to 
several hours) requires labels with commensurate half-lives.1-7  
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Measurement of the effective specific activity (ESA) of 64Cu is important to the 
application of 64Cu because metal impurities present in the sample can have a negative impact on 
radiolabelling.8  The current and most common method for measuring the effective specific 
activity (ESA) of 64Cu productions is by titration with a suitable chelator such as 1,4,8,11-
tetraazacyclotetradecane-1,4,8,11-tetraacetic acid (TETA).9,10 This approach measures the ESA 
relative to the metal’s affinity for the TETA molecule but does not distinguish between the 
different types of metals present in the sample.  Other methods that have been developed to 
measure ESA of 64Cu include voltammetry, liquid chromatography-mass spectrometry (LC-MS), 
and inductively coupled plasma mass spectrometry (ICP-MS).  Voltammetry measures the 
amount of cold (non-radioactive) copper contamination but not the amount of the other 
contaminating metals.11  The recently reported LC-MS method measures the concentration of 
metal contaminants present that bind to a particular chelator, however it is a relatively expensive 
and complex method that may also require additional method development for new chelators.8  
While ICP-MS is a sensitive multi-element analysis technique that can simultaneously determine 
the concentration of all the metal contaminants in the sample, it is also an expensive technique 
and not readily available at all institutions for radioactive samples.  For this reason, a method is 
 
 
Figure 2-1.  The decay scheme for 64Cu showing decay by β+, β-, and ε. 
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desired that is robust and will identify and measure trace amounts of metal impurities in samples 
of 64Cu.    
In this chapter a high-performance liquid-chromatography (HPLC) ion-chromatography 
method that measures trace amounts of metals (ppb) was used to measure the transition metal 
contaminants in twenty different 64Cu lots produced at Washington University School of 
Medicine.  This method was validated by comparing the data to the current TETA titration 
method and ICP-MS.  Ion chromatography is simple, fast (<25min), and practical for routine 
measurement of the cold metal contaminants in a radioactive sample of 64Cu.  Due to the high 
sensitivity of this technique, ion chromatography was instrumental in determining separation 
strategies for isotope harvesting experiments where radioactive tracers could not be employed. 
  
Materials and Methods 
TETA Titrations: Trace metal grade reagents including ammonium acetate, ammonium 
hydroxide, and hydrochloric acid were obtained from Sigma Aldrich (St. Louis, MO).  1,4,8,11-
tetraazacyclotetradecane-1,4,8,11-tetraacetic acid was obtained from Macrocyclics (Dallas,TX).   
64Cu was produced in house at Washington University using an automated module.12  2 mL 
microcentrifuge tubes were acid washed in 50% nitric acid bath overnight before use.   TLC 
plates (silica gel 60F-254 glass 5x10cm 0.25mm precoat) were obtained from Millipore 
(Billerica, MA). 
Ion Chromatography:  PDCA (1.4 mM pyridine-2,6-dicarboxylate / 13.2 mM 
Potassium hydroxide / 1.12 mM Potassium sulfate / 14.8 mM Formic acid) PAR (4-(2-
pyridylazo)resorcinol), and PAR dilutent (1.0 M 2-dimethylaminoethanol/0.50 M Ammonium 
hydroxide/0.30 M Sodium bicarbonate) were obtained from Dionex.  TraceSELECT Ultra, ACS 
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reagent for ultratrace analysis water and nickel, copper, cobalt, iron, and zinc and TraceCERT 
atomic absorption standards 1000 mg/L were obtained from Sigma (St Louis, MO). 
Mass Spectrometry:  A PerkinElmer NexION 300X ICP-MS was used for all ICP-MS 
measurements.  Linearity standards were prepared from commercial multi-element and single-
element solutions (High Purity Standards).  The diluent for samples and standards was a solution 
of 3% w/w HNO3 that was prepared from Optima grade nitric acid (Fisher Scientific) and fresh 
18.2 MΩ-cm water (EMD Millipore) 
 
TETA Titration 
 The TETA titration method was based on that reported previously.8  7.4 MBq (20 µL) of 
64Cu was added to eight different concentrations of TETA in ammonium acetate pH 5.5 ranging 
from 4.3 × 10-4 nmol to 6.3 × 10-1 nmol. Final volume was brought to 100 µL using 0.5 M 
ammonium acetate buffer pH 5.5.  The solutions were placed in an agitating incubator at 80 ºC 
for 20 min.  Solutions were cooled to room temperature and then centrifuged.  A 1µL sample 
from each TETA concentration along with 1 µL unbound 64Cu was analyzed for percent 64Cu 
incorporation determined by Thin Layer Chromatography (TLC) using silica plates and 1:1 
mixture of 10% ammonium acetate and methanol as an eluent.  Plates were analyzed using a 
Radio TLC Plate Reader (Bioscan, Washington DC).  Data was plotted as molar concentration of 
TETA vs. % 64Cu incorporation. The curve was fit using a sigmoid plot fit program in Prism 
(Graphpad, California).  The EC50 value, concentration of TETA that bound to 50% of the 64Cu, 
was determined from this fit. The ESA was set equal to two times the EC50 value.  
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Ion Chromatography 
Twenty completely decayed 64Cu lots of varying activity at end of bombardment were 
measured at two concentrations in triplicate.  Each sample was originally brought to 1mL by 
adding TraceSELECT Ultra water (Sigma), then samples were diluted to 74 kBq/µL (back 
calculated activity to end of bombardment for the sample) with TraceSELECT Ultra water 0.740 
kBq and 18.5 MBq from this dilution were brought to a final volume of 3 mL with 
TraceSELECT Ultra water.  The concentrations were adjusted depending on the amount of metal 
contamination present.  The lower concentration was typically used to measure contaminating 
nickel at 1-10 µg/L and the higher concentration solution was used to measure the copper, iron 
and zinc contaminants at 1-10µg/L.  A metal-free HPLC system equipped with a GP-50 pump, 
AD20 detector, and a PC10 post column delivery system was used with a Dionex CS5A 2-mm 
Transition Metal Column.  1mL of each sample was injected into the metal free ion 
chromatography system.  The eluent (1.4 mM pyridine-2,6-dicarboxylate / 13.2 mM Potassium 
hydroxide / 1.12 mM Potassium sulfate / 14.8 mM Formic acid) was passed through the column 
at 0.30 mL/min.  As the metals elute from the column they pass through a mixing loop with 1.0 
M 2-dimethylaminoethanol/0.50 M Ammonium hydroxide/0.30 M Sodium bicarbonate 
containing 0.06g/L 4-(2-pyridylazo) resorcinol (PAR) at 0.15 mL/min.  This post column reagent 
flow is controlled by the PC-10 post column delivery system using pressurized helium.  During 
this time the metals complex with the PAR dye prior to UV analysis at 530 nm.  Calibration 
curves that ranged from 1 µg/L to 10 µg/L were made for copper, nickel, zinc, cobalt, and iron 
using TraceCERT atomic absorption standards, 1000 mg/L in nitric acid.   
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ICP Mass Spectrometry 
Linearity standards were prepared in 3% HNO3 from a commercial high purity standards 
multielement solution containing all elements of interest.  Individual single-element standards of 
Zn and Ni were also prepared in order to measure and normalize for mass fractionation among 
Ni isotopes.  The internal standards Sc, Ga, and In were added to all samples and linearity 
standards in order to compensate for matrix effects and instrument sensitivity drift. 
Samples were analyzed using a PerkinElmer NexION 300X ICP-MS operated in KED 
(Kinetic Energy Discrimination) mode.  All isotopes were analyzed twice, once at a helium flow 
of 2.5 mL/min (low flow) and 4.5 mL/min (high flow).  High-flow results are reported all 
elements measured.  
 
Results  
TETA Titrations 
ESA as measured by TETA titration over the twenty lots varied between 49.6 and 973.1 
GBq/µmol.   
 
Ion Chromatography 
Calibration curves for five different metals including iron, copper, nickel, zinc, and cobalt 
were linear at concentrations ranging from 1µg/L to 10µg/L with R2 values of 0.95 or greater 
(Figure 2-2).  Standard error of the estimate for the five curves were calculated to be 2.01 µg/L 
for iron, 0.56 µg/L for copper, 0.48µg/L for nickel, 0.42µg/L for zinc, and 0.05µg/L for cobalt.  
The lower limit of detection was 1µg/L for copper and cobalt, 2µg/L for nickel and iron, and 
3µg/L for zinc.  Figure 2-3 shows an overlay of the 5µg/L calibration sample with a blank.  The 
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absorbance of the five different metal-PAR complexes at 530 nm are different when measuring 
the same concentration.  This can be seen in Figure 2-3 and is responsible for the different 
slopes shown in Figure 2-2.   
Ion chromatography yielded the concentration (mg/L) of cold copper, nickel, zinc, and 
iron that were present in the 64Cu samples diluted to 1mL, cobalt was not detected as a 
contaminant.  Figure 2-4 shows the amount in mg/L of nickel, copper, iron, and zinc measured 
by IC compared to ICP-MS of each of the twenty samples measured with the exception of zinc 
which only shows IC measurement. 
 
  
 
 
 
 
Figure 2-2.  Calibration curves for assessment of metal contamination using ion 
chromatography.  Five calibration curves were made for iron, copper, nickel, zinc, and cobalt.  
R2 values for these curves were > 0.95.  The lower limit of detection that resulted in a linear 
curve for copper and cobalt is 1 ug/L, iron and nickel is 2 ug/L, and zinc is 3 ug/L.  All 
samples were brought between the lower limits and 10 ug/L for analysis. 
34 
 
 
 
 
 
 
Figure 2-4.  Ion Chromatography vs ICP-MS.  The amount in mg/L of nickel, copper, iron, 
and zinc measured by IC compared to ICP-MS of each of the twenty samples measured with 
the exception of zinc which only shows IC measurement. 
 
 
 
Figure 2-3.  Ion Chromatography of the 5µg/L calibration standard.  From left to right peaks 
represent iron, copper, nickel, zinc, and cobalt.  The absorbance at 530nm was measured.   
35 
 
When constructing the calibration curves zinc contamination was an issue.  All glassware 
and vials must be acid washed for at least 24 hrs in 50% HNO3 to minimize contamination.  Zinc 
was a perpetual contaminant in the autosampler vials so manual injections using 5.0 mL syringes 
(Thermo Scientific SUN-SRi™ Luer-Slip Syringes) were used and found to be free of zinc 
contamination.  Additionally TraceSELECT Ultra water (Sigma, St Louis) had to be used for all 
dilutions as the in-house milli-Q water contained as much as 3 ppb zinc.  Storage of the sample 
in 2.0 mL acid washed microfuge tubes for a significant amount of time (weeks or more) will 
lead to zinc leaching out from the plastic, therefore it was best to make all dilutions immediately 
prior to analysis in order to minimize this contamination. 
 
Mass Spectrometry  
ICP-Mass Spectrometry was used as the “gold standard” method to validate ion 
chromatography for determining amounts of metal impurities. The Bland-Altman method13 was 
used to compare the ion chromatography measurements with those from ICP- Mass 
Spectrometry and the results are graphically shown in Figure 2-5.  Iron had a bias of -33.2μg/L 
with a 95% confidence interval of -126μg/L to 60.2μg/L and copper, with the exception of lot #8 
which was omitted due to high variation, had a bias of -11.1μg/L with a 95% confidence window 
of -78.7μg/L to 56.6μg/L.  Nickel was separated into two calculations, for lots under 20mg/L the 
bias was -0.241mg/L and had a 95% confidence window from -1.11mg/L to 0.602mg/L and at all 
concentrations ranging up to 50mg/L the bias was -0.755mg/L with a 95% confidence window of 
-4.1mg/L to 2.6mg/L.     
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The difference in zinc measurements was quite large and it is likely that the samples were 
contaminated with zinc between the two measurements, likely caused by zinc leaching from the 
plastic microfuge tubes used to transport the samples to the ICP-MS lab, and therefore the results 
are not shown.  ICP-MS did show very small concentrations of cobalt (0.34-12 μg/L) which was 
much lower than the detection limit of the Ion Chromatography method and considered 
negligible compared to the other metal contaminations.     
 
 
 
 
 
 
Figure 2-5.  Bland-Altman plots comparing ion chromatography to ICP-mass spectrometry. 
Iron (squares), copper (circles), and nickel (triangles) < 20mg/mL top left all concentrations 
top right. 
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Discussion 
TETA titration, ion chromatography, and ICP mass spectrometry data were compared in 
order to analyze large variances in ESA.  TETA values in seventeen lots were graphed against 
true specific activity (64Cu radioactivity per µmol copper) in Figure 2-6, two lots were left out 
due to variation from the trend likely a result of TETA titration error. A link between cold copper 
contamination and effective specific activity is observed which was expected.  The ESA values 
were lower than the true specific activity values.  This difference is likely due to the contribution 
of other metals such as nickel and iron binding to the TETA molecule thus affecting the 
measurement.  The log K values for copper, nickel, and iron for TETA are 21.7, 19.91, and 13.1 
respectively and the moles of TETA remaining compared to the moles of nickel and iron 
available for binding are quite small and thus both are believed to have some effect on overall 
specific activity.       
 
Figure 2-6.  Effective vs True Specific Activity.  The graph of effective specific 
activity (TETA) vs. true specific activity (ICP-MS) illustrates the relationship 
between copper contamination and TETA specific activity. 
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Sources of copper contamination are currently being explored.  One potential source is 
the raw 64Ni material.  Other potential sources are the reagents used in the purification chemistry 
or contamination during the electroplating process. 
For routine analysis the TETA and ion chromatography method are useful in determining 
impurities and ESA of different lots of 64Cu.  Ion chromatography is useful as a troubleshooting 
method as it can show which metals are contaminating a sample and help to determine the source 
of the contamination.  ICP mass spectrometry is useful for looking at all the impurities that could 
be present and also to confirm routine measurements. 
 
Conclusions 
Ion chromatography is a good method for routinely analyzing trace amounts of transition 
metals in radioactive samples.  This method can measure in the parts per billion range and 
therefore large amounts of radioactivity do not have to be injected in order to get an accurate 
measurement.  The main drawback for measuring metal contaminants in 64Cu productions is 
determining the dilution factor that brings the low levels of copper and iron to the 1-10 µg/L 
range required for detection.  More work will be done to determine the source of the cold metal 
contaminants, steps that can be done to minimize or eliminate them, and at what concentration 
these impurities have the largest effect. 
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Introduction 
 FRIB is currently scheduled for completion in 2022 and will have the capacity to 
accelerate uranium up to energies of 200 MeV/nucleon, and lighter ions to slightly higher 
energies, with a beam power as high as 400 kW to produce a broad range of rare radioisotopes 
through fragmentation.  FRIB will provide these high-power beams at intensities several orders 
of magnitude higher than are currently obtainable, which will provide the most intense secondary 
ion beams of these rare isotopes in the world.1  The unused radioisotopes will be stopped in the 
cooling water in FRIB’s primary beam dump, a spinning titanium container with cooling water 
circulating at ~300 gallons per minute to dissipate the large heat load and provide a vehicle for 
the storage and disposal of unused radioisotopes.  The technology to pass large volumes of 
cooling water through ion-exchange columns to remove radioisotopes has been well-developed 
in the nuclear power industry,2  and the ability to conduct radiochemical separation and 
harvesting of certain long-lived radioisotopes from the cooling water of the primary beam dump 
has been designed into FRIB.3  Developing aqueous extraction and separation methods for the 
ancillary harvesting of specific radioisotopes from FRIB’s beam dump would be beneficial to 
many isotope users without interfering with the primary users’ experiments.   
Radioisotope harvesting of 13N has been conducted in the past from the interaction of a 
fast 14N primary beam with water,4 but harvesting experiments with heavier beams had not been 
conducted before this work.  In the study just cited only a few radioactive products could be 
produced in the water and 13N was found to be the predominant activity.  Experiments were 
needed, where collection of the secondary beam and fragmentation products is achieved, in order 
to determine the viability of “harvesting” isotopes of interest from an aqueous beam stop. 
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In order to collect the secondary beam an end station was designed that could stop the 
ions in an aqueous target.  In this chapter this end-station design and construction is discussed in 
detail and results of testing using an analyzed high-energy beam of 24Na are presented.  The 24Na 
collected in the water was isolated in order to obtain an extraction efficiency.  Using this end 
station, the efficiency with which this isotope, and other isotopes of interest, would be extracted 
from water could be measured, optimized and compared to the direct measurement of the 
production rate in the A1900 separator (see below).  This efficiency could then be used to 
estimate the activity of isotopes of interest that would potentially be extracted from the FRIB 
beam dump.5,6   The development of a water-based target system for harvesting radioisotopes at 
the NSCL was the initial step for the proof-of-principle experiments to harvest useful 
radioisotopes from FRIB. 
 
Materials and Methods 
End Station Design 
 In order to collect and isolate specific radioisotopes of interest from a cocktail of other 
isotopes produced at the NSCL, a complete, remote-controlled, water target system was 
designed, constructed and tested with a radioactive beam. The following features were included 
in the final system:   
 The system had to be completely automated, remote-controlled and operated from outside 
the experimental vault during beam irradiation for radiation safety reasons.  
 This system had to be capable of performing several remote water collection/storage 
cycles before being recharged in order to conduct systematic studies with various beam 
conditions (six in the present case).  For example, the purity or intensity of the analyzed beam 
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could be changed and deposited into separate water volumes.  Thus, a water manifold system to 
move volumes of water to/from the target cell into separate collection vessels was necessary. 
 During the previous light-ion extraction experiments,4 radiolytic production of 
radioactive gases was observed, thus the target water cell was designed to include a gas manifold 
system to capture off-gases and to purge the target water with helium to remove dissolved gases 
before irradiation. In addition, the target system was designed to be physically isolated from the 
accelerator vacuum system by passing the high-energy beam through an air gap before reaching 
the water target. 
     These features were realized in a stand-alone unit with a main enclosure housing the 
hardware and plumbing and a second enclosure housing the electronics, all controlled remotely 
over ethernet. There are three main components to the stand-alone unit: first, a water-holding 
reservoir in which aliquots of purified water were held in individual commercially-available 
HDPE (high density polyethylene) containers.  There are six 175 mL conical HDPE bottles 
(Nalgene, 3143-0175) in the water reservoir system, each filled with 100 mL of distilled water 
(Sigma-Aldrich, 7732-18-5) prior to beam collection.  The water in each reservoir was sparged 
with helium for ~30 minutes prior to irradiation. A flow sensor (Omron Electronics Inc – EMC 
Div, D6F-P001A1) was used to ensure that the helium, regulated by an electronic valve (SMC, 
ITV1010-21N1BS4), was properly flowing during sparging and when pushing the water though 
the manifold system to/from the target cell.  A pressure sensor (Honeywell Sensing and Control, 
SSCSANN001BGAA5) was used to monitor the irradiation cell for gases produced during beam 
collection.  Second, a custom irradiation cell was built, into which water was transferred from the 
holding reservoir, for stopping and collection of the beam particles.  The target cell had a thin 
entrance window (8 µm Kapton) and was constructed from PTFE (polytetrafluoroethylene).  The 
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internal volume of the irradiation cell took the shape of a truncated cone for containing any 
divergence of the stopping secondary beam, see Figure 3-1.  Third, a movable carousel of 
commercially available PTFE bottles was included for the transfer and temporary storage of the 
irradiated water samples.  After irradiation, the water was transferred to a collection bottle via a 
tube supported on a pneumatic linear actuator (SMC, CDJ2KB16-45-B) that extended into the 
bottle to capture any spraying during liquid transfer operations. The actuator was retracted before 
movement of the carousel to the next collection bottle.  Two magnetic sensors (Cherry, 
MP201802) on the linear actuator were used to confirm that the actuator rod was in the up 
position before rotating the carousel or that it was the down position and the tubing was in the 
bottle, ready for dispensing water from the target cell.  There were ten PTFE collection/storage 
bottles (Cole-Palmer, 015.150.2) in the 35.6 cm diameter carousel for post-irradiation retrieval of 
the water.  A stepper motor (Lin Engineering, 85BYGH450A-08), controlled by a stepper motor 
drive (Lin Engineering, CW250), was used to rotate the carousel and position the collection 
bottles as necessary.  Four photo sensors (Sharp, GP1A57HRJ00F) viewed notches cut into the 
carousel plate to identify each of the ten bottle positions. A fifth photo sensor was used to center 
each bottle prior to reading the position identification and a capacitive sensor (Carlo Gavazzi, 
CD50CNF06NO) was used to determine if the collection bottle contained water thus ensuring 
that a new sample would not be delivered to a filled bottle. All components of the system that 
could come into contact with water were metal-free (or Teflon-coated) to reduce metal 
contamination and the loss of aqueous radioisotopes by plating onto metal surfaces.  The end 
station incorporated metal-free, air-operated, normally closed, two-way valves (SMC, LVQ20-
Z07N) controlled by low-voltage (5V) solenoids (SMC, SY3A00-5U1, manifold: SS5Y3-10F2-
12BS-N7D0).  FEP (Fluoroethylpropylene) fittings (SMC, LQ3 Series) and Teflon tubing (SMC, 
46 
 
TIHA07N-33) were used if they came in contact with water.  A Measurement Computing I/O 
device (Measurement Computing, USB-1208LS, USB-SSR24, SSR-ODC-05) was used to 
communicate with the sensors and to control the stepper motor and electronic valve regulators 
(for both the helium used for sparging the water and the air for operating the metal-free valves.    
The entire end station was remotely operated using LabVIEW software (National Instruments, 
776670-35). 
 
 
 
Figure 3-1.  Schematic design of the PTFE water target cell containing 100 mL of water. 
Dimensions are in inches [mm], angles in degrees.  
 
100 mL Secondary beam 
     24Na 
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  A concern during operation was the possible over-pressurization of the irradiation cell 
due to localized heat production and radiolysis of water, producing radioactive and other gases.  
This concern was addressed by programming the LabVIEW system to open the helium exit valve 
on the top of the cell and venting the cell into a 152 m (500 ft) length of 6.35 mm (¼ inch) tubing 
if the target cell pressure exceeded 0.14 atm above gauge (2 psig) as determined by the pressure 
sensor installed to monitor the irradiation cell.  This length of tubing was calculated to exceed 
the distance traversed by the diffusion of 11CO2 at atmospheric pressure through the tube within 
10 half-lives of 11C. 
In addition to the safety checks built into the LabVIEW control program, two webcams 
and LED lighting strips were added to allow visual monitoring of the end-station.  Remote 
desktop connections were used to control the LabVIEW programs running in two laptop 
computers physically wired to the end-station electronics in the vault. A radiation monitoring 
system was also incorporated into the end-station to qualitatively measure the presence of 
activity in the proper locations.  The radiation detector system consisted of eight CsF detectors 
each with a photomultiplier tube, a fast discriminator and a scaler.  These detectors were placed 
at different locations within and outside the target assembly to monitor the flow of radioactive 
solutions into different collection vessels during the experiments to ensure the radioactivity was 
moving only to the desired location.  A schematic diagram of end station is shown in Figure 3-2, 
and photos of the completed system are shown in Figure 3-3.  The end-station was fabricated at 
Hope College and then installed in the S1 vault at the NSCL. 
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Figure 3-2.  Schematic diagram of the complete end-station.  The doors to the end-station are 
shown in the open position, and the reservoirs at the top and the carousel at the bottom are 
apparent. The electronics control box is in the background at floor level. 
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Figure 3-3.  Photographs of the water cell collection end-station. (Left) Installation in the vault 
where the beam enters from the left, A is the side of the isolation box that holds the target cell 
and associated plumbing (see Fig. 3-2). B houses the electronic controls and C is a laptop that 
controls the system. (Center) Side view of the target end-station that shows D: the water 
reservoir system, E: the PTFE target cell and F: the rotating collection bottle system, (Right) 
Close up of the end of the beam line and G: water cell window, H: a removable scintillator in 
front of the target assembly, I: beam collimator. 
 
Simulation Results 
 As part of the planning process, modeling of the radioisotopes delivered to the water cell 
by the A1900 and their decay products was carried out using the LISE++ code5 with the EPAX3 
cross sections6 and the Nucleonica© decay engine,7 respectively.  The information from these 
programs was only used to estimate the amount of radioactivity in the solutions collected and to 
identify potential contaminants in the secondary beam prior to the measurements.  These first 
tests of the production and collection focused on 24Na because of its convenient 14.997-hour 
half-life and its characteristic high-energy gamma-ray emission which allowed identification and 
quantization by offline gamma-ray spectroscopy.  It was decided to produce the 24Na from a 40Ar 
primary beam based on the high availability of the argon beam and the relatively efficient 
delivery of 24Na by the separator. Calculations using the LISE++ code indicated that significant 
A 
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amounts of other radioisotopes would not be present in the analyzed 24Na beam, therefore neither 
extraction nor separation was necessary post irradiation, allowing the focus to remain on 
determining the overall collection efficiency. 
The LISE++ calculation (version 9.4.15) for an 40Ar primary beam (140 MeV/u) at the 
maximum intensity available at the NSCL of 75 pnA,8 using an 1151 mg/cm2 thick beryllium 
production target and a 289 mg/cm2 aluminum wedge with a 1 percent momentum acceptance at 
the Image-2 position9 predicted a 70% pure beam at the collection station that would result in 
~1.7 ×1010 24Na particles at (~88 MeV/u at the A1900 focal plane) 85 MeV/u after the water 
target window after the minimum collection time of one hour (see below).  Table 3-1 provides a 
list of the isotopes in the separated secondary beam that have a production rate greater than 1 s-1 
(note that the predicted production rate of 24Na under these conditions is 4.62×106 s-1). The next 
most abundant isotope was stable 25Mg at 28% of the total rate while the remaining 2% consisted 
of a few nuclides that do not contribute to the radioactivity levels after a five minute cooling 
period. If all the kinetic energy of the incident secondary beam was absorbed in the water there 
would be a negligible temperature increase of <0.05 K in the 100 mL of water in the irradiation 
cell.  This value was calculated for the total collection time, the production rate and kinetic 
energy of each nuclide.  Table 3-1 shows that the only significant activity delivered to the water 
was 24Na, 
 
Table 3-1. Predicted production rates of isotopes greater than 1s-1  
Nuclide Half-life  Focal Plane Rate (s-1)            Activity  
(Bq, 5m EOB) 
 26Al 717 ky 8.97E+01 ~0 
 25Mg Stable 1.84E+06 0 
 24Na 14.997 h 4.62E+06 2.1E+05 
 23Ne 37.2 s 1.37E+05 90. ~  ~0 
 21F 4.16s 5.63E+01 0 
 20O  13.51 s 4.30E +03 ~0 
 17C  193 ms 2.43E+01 0 
Total       6.60E+06 
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however, the fast beam will react with the hydrogen and oxygen nuclei in the water to produce 
some 18F, 15O and 11C.  This production is more difficult to model so the samples were held for 
about 8-24 hours prior to shipping to allow these intermediate half-life isotopes to decay. 
 
24Na Beam Collection 
The water target system was used to collect four separate samples during a 24 hour 
period.  As in the simulations described above, the 40Ar18+ primary beam at 140 MeV/u was 
fragmented in a beryllium target to produce 24Na.  The 24Na ions were separated in the A1900 
projectile fragment separator9 and arrived at the focal plane with an energy of ~88 MeV/u.  The 
primary beam intensity was attenuated by a factor of ~10 for the first two sample collections, 
then delivered at the full intensity of ~75 pnA for two additional sample collections. The exact 
experimental parameters are listed in Table 3-2. The primary beam was incident on an 1151 
mg/cm2 beryllium target, the A1900 separator was set for maximum production of the 24Na 
fragment with momentum acceptance slits adjusted to a 1% momentum full acceptance using a 
289 mg/cm2 aluminum wedge in the center of the A1900 separator, and the focal plane (FP) 
mass-selection aperture was 10 mm. The beam intensity and purity were measured using the 
common delta-E/Time-of-Flight technique with the standard A1900 focal plane silicon-PIN 
diode and cyclotron RF signal prior to delivery of the beam to the experimental end station.  The 
24Na production rate at the focal plane was ~1.04(0.02)x105 pps 24Na per pnA of primary beam 
and the exact composition of the secondary beam during the sample collections, i.e., 72(2)% 
24Na was in good agreement with the simulation.  In addition, the “FP plastic scintillator” made 
of 150 m BC-400 (CRAD06) was positioned in the path of the beam for beam normalization 
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(calibration) runs and removed when collecting the 24Na secondary beam in the water.  The 
scintillator was used to directly measure the beam intensities at rates below ~106 pps.  During the 
sample collection runs the beam exited the vacuum system through a 75 µm zirconium exit 
window, followed by a 89 mm air gap, entered the water cell through a 8 µm Kapton window, 
and had a calculated range of  ~11 mm in the distilled and degassed H2O (73 mm thick).  The 
primary and secondary beam intensities were recorded by various intercepting and 
 
Table 3-2.  A1900 fragment separator and beam line settings for 24Na production. 
Block Description         Value    
Primary Beam Target Beryllium 1151 mg/cm2 
D1 Bρ Dipole Magnet 3.16650 Tm 
D2 Bρ Dipole Magnet 3.16650 Tm 
I2 Slits 1% Momentum Acceptance (dp/p) 60 mm 
I2 Wedge Aluminum 289 mg/cm2 
D3 Bρ Dipole Magnet 3.01230 Tm 
D4 Bρ Dipole Magnet 3.01230 Tm 
CRAD06 BC-400 Scintillator (removable) 150 µm 
D5 Bρ Dipole Steering Magnet 3.01230 Tm 
D6 Bρ Dipole Steering Magnet 3.01230 Tm 
Exit Window Zirconium 75 µm 
Air Gap Air 88.9 mm 
Collimator Aluminum, 3.175 cm diameter 6.35 mm 
CRAD02 BC-400 Scintillator (removable) 150 µm 
Water Target Window Kapton 8 µm 
Water Target Liquid water 73 mm 
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non-intercepting detectors during different phases of the experiment (Figure 3-4). A 6.35mm 
thick aluminum collimator was placed in front of the exit window scintillator (at the end-station) 
to ensure only the particles that entered the water cell were counted.    
 
 
Figure 3-4.  Schematic diagram of NSCL indicating approximate locations of intercepting and 
non-intercepting detectors (Z001I-C, Z001F-C, Z013L-C, CRAD-06 and CRAD-02).  
 
The FP scintillator could only be used to monitor the secondary beam at lower intensities 
(with saturation occurring around 106 pps).   In order to collect the maximum amount of 24Na and 
not be limited by the scintillator, a non-intercepting beam monitor was necessary that: 1) could 
measure high-intensity primary beam directly or indirectly, 2) could continuously monitor the 
beam, and 3) had a linear relationship to the counting rates observed in the scintillators at lower 
beam intensities.  The secondary beam rate was indirectly determined using two different 
methods.  In the first method the 24Na rate at the end station was calculated from the FP 
scintillator by constructing a calibration curve obtained from measurements of the beam at 
various intensities using a series of Faraday cups that intercept the primary beam, the Z001I-C 
and Z013L-C non-intercepting primary beam monitors, and the FP scintillator in the secondary 
beam path.  The Z001I-C is a non-intercepting beam monitor just before the A1900 production 
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target that provides a signal proportional to the primary beam intensity.  The Z013L-C non-
intercepting beam monitor in the first dipole of the A1900 also provides a signal proportional to 
the primary beam intensity.  During the sample collection runs, when the scintillator was 
removed from the beam, data from the Z001I-C and Z013L-C non-intercepting beam monitors 
were used to determine the secondary beam intensity.  The calibration curve obtained for the 
Z013L-C beam monitor is shown in Figure 3-5.  The second method relied on using the 24Na 
production rate measured at the A1900 focal plane prior to the collection runs, as indicated 
above, combined with an estimate of the primary beam intensity. The data from non-intercepting 
Z001I-C beam monitor was used to infer the primary beam current during the run using a 
calibration established with a Faraday cup that intercepted the primary beam at the A1900 target 
position (Z001F-C).  
 
 
 
Figure 3-5.  Calibration curve for the non-intercepting primary beam monitor Z001I-C 
versus the intercepting Z00lF-C Faraday cup signal intensity. 
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After the isotope collections were complete, the samples were transported approximately 
one day later to Hope College for preparation and analysis.   The 100 mL samples of water were 
reduced to ~15 mL via gentle evaporation and quantitatively transferred to an x-ray fluorescence 
(XRF) cup with minimal air gaps, which was then capped with an 8 µm Kapton window for 
offline gamma spectrometry. Each sample was measured repeatedly for at least 20 minutes over 
a 5-day period in a low-background radiometric detection facility at Hope College.  The three 
low-background systems at this facility consist of three Ortec 20% high-purity germanium 
detectors with resolutions of 1.2, 2.5, and 4.1 keV at 1369 keV, shielded by layers of aluminum 
(0.5”), copper (0.5”) and lead (4”).  Gamma ray spectra were recorded and peak integrations and 
background subtractions were performed using a linear function background fit to each peak for 
the 1369 keV gamma ray of 24Na.  Besides the 511 keV peak, there were no other radionuclides 
greater than 0.5% of the 1369 keV peak detected in the samples. These detectors were calibrated 
with known sources for energy calibration and absolute counting efficiency.  The number of ions 
implanted in the water were then calculated and used to determine the collection efficiency.   
 
Experimental Results 
The primary beam intensity was calculated using the Z001F-C vs Z001I-C calibration 
curve (Figure 3-5) and the integrated data for Z001I-C obtained during each run.  As the 
relationship between Z001F-C and 24Na was 1.04(0.02)×105 24Na/pnA (where pnA is the 
intensity of the 40Ar primary beam measured by the Z001F-C detector), obtained from the beam 
analysis conducted by the A1900 group, the 24Na rate at the focal plane could be calculated.   
Table 3-3 contains a summary of the numerical results obtained for the sample collection runs.  
The gamma-ray spectroscopy of the samples yielded results having a precision of ~1%. This 
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value is the relative experimental precision of multiple measurements of the same aliquot. The 
calculated extraction efficiencies, taken as the ratio of the number of particles at the A1900 focal 
plane and the number of particles observed in the water was 20 ± 1%.  This modest collection 
efficiency is believed to be due, in part, to beam losses between the focal plane and the end-
station.  The estimated losses during the handling of the aqueous 24Na solutions were less than 
10%.  Thus, we observed approximately 70% loss in beam transmission between the focal plane 
and the target.   The typical transmission from the A1900 to end-stations at the NSCL is 
approximately 80 to 90% and thus the observed losses are surprisingly large.  Since the goal of 
the experiment was not to obtain maximum yield of the 24Na particles, but rather to demonstrate 
isotope collection and subsequent harvesting, the beam line transmission was not optimized. 
 
Table 3-3. Summary of the 24Na collection efficiencies. 
24Na particles         
  Run 1 Run 2 Run 3 Run 4 
γ-spectroscopy 
5.84E+08 
± 4E+06 
7.19E+08 
± 5E+06 
1.90E+10 
± 1E+08 
1.85E+10 
± 1E+08 
Focal Plane Particles Calculated 
by FC (Z001I-C) 
2.83E+09  
± 9E+07 
3.8E+09  
± 1E+08 
9.5E+10  
± 3E+09 
8.8E+10  
± 3E+09 
Extraction efficiency 0.21 ± 0.01 0.19 ± 0.01 0.20 ± 0.01 0.21 ± 0.01 
Focal Plane Particles Calculated 
by scintillator (CRAD06) 
2.8E+09  
± 1E+08 
3.6E+09  
± 1E+08 
9.0E+10  
± 4E+09 
8.4E+10  
± 3E+09 
Extraction efficiency 0.21 ± 0.01 0.20 ± 0.01 0.21 ± 0.01 0.22 ± 0.01 
 
Conclusions 
A water filled collection system was constructed and has been successfully used to stop a 
beam of ~85 MeV/u 24Na produced at the NSCL.  The end station operated flawlessly during 
irradiation and multiple samples were collected remotely at particle intensities of ~2x106 pps.  
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The samples were transported and characterized off-line in a remote location by gamma 
spectroscopy using HPGe detectors. Two independent methods of calculating the secondary 
beam intensity agreed within ~1% providing confidence that the total beam intensity was well-
known.  There were no observed release of radiolytic gases from the system nor any spills or loss 
of radioactive liquids.  This work compromises the first step in providing the viability of isotope 
harvesting from heavy-ion beam facilities using a water activity accumulation cell.  
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Feasibility of Isotope Harvesting at a Projectile Fragmentation 
Facility:  67Cu 
[This work has been published previously as Tara Mastren, Aranh Pen, Graham F. Peaslee, Nick 
Wozniak, Shaun Loveless, Scott Essenmacher, Lee G. Sobotka, David J. Morrissey, and Suzanne 
E. Lapi, Scientific Reports. 2014] 
 
 
 
 
 
 
 
 
 
 
61 
 
Introduction 
With the successful construction and validation of the end station discussed in chapter 2, 
we are now ready to move onto one of the isotopes of interest listed in Table 1-2.  The isotope 
we chose to start with, which can be used in medicine as a therapeutic isotope, is 67Cu.2-4  Its 
relatively long 2.58 day half-life is ideal for labeling antibodies that typically have several-day 
biological half-lives and its maximum β- energy of 562 keV makes it a good candidate for 
radiotherapy.   
Obtaining therapeutic doses that are typically on the order of hundreds of mCi/patient5 
has proved to be quite difficult due to inconsistent production and no reliable supply.5-8  67Cu can 
be made via several nuclear reactions: 68Zn(p,2p)67Cu, 70Zn(p,α)67Cu, 67Zn(n,p)67Cu, and 
68Zn(γ,p)67Cu; however each reaction has practical drawbacks.  For example, 68Zn(p,2p)67Cu has 
a small but broad (in energy) cross section (Figure 4-1) and in order to efficiently produce the 
 
 
Figure 4-1.  68Zn(p,2p)67Cu excitation function showing low but broad (in energy) cross 
section.1  
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large quantities needed for therapeutic doses thick targets and high-energy proton accelerators, 
such as those at Brookhaven9,10 or Los Alamos National Laboratories,11 need to be employed.  
These facilities have missions that make routine production of 67Cu problematic.5  Studies at 
several facilities of the 70Zn(p,α)67Cu reaction have obtained varying yields and the production of 
the large quantities needed for therapeutic studies are challenging with this method.12-14  
Production via the 67Zn(n,p)67Cu and 68Zn(γ,p)67Cu reactions have undesirable side reactions and 
concerns about waste products create challenges for their large scale use.5  It is estimated that 
FRIB will be able to produce a saturated activity of 67Cu as high as ~2 Ci depending on the 
primary beam15 so that harvesting of 67Cu could provide a consistent supply of this isotope.   
Figure 4-2 shows the decay schemes for isotopes at the bottom of the A=67 mass 
parabola.  It is important to note that good separation from gallium must be achieved due to the 
similar half-life, emitted gamma rays, and likely significant production rate of 67Ga.15  
Additionally the production of 67Ni (t1/2 = 50s) will contribute to the overall 67Cu production rate 
(as the former decays to the latter) resulting a net production of 67Cu greater than its primary 
production.  Reported here are the results of these studies and the observation of relatively high 
chemical extraction efficiency. 
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Methods 
Beam Collection and Calibration 
A 25 particle-nA 130 MeV/u 76Ge beam was fragmented using a 510.8 mg/cm2 thick beryllium 
production target in the A1900 projectile-fragment separator.16  After fragmentation of the 
primary beam, 67Cu was selected using the A1900 with a 236.7 mg/cm2 aluminum wedge in the 
center, the focal plane (FP) mass-selection aperture set to 10 mm, and the momentum acceptance 
slits open to 2% (full momentum acceptance).  Table 4-1 lists the exact experimental parameters 
used in the separator and beam line.  The beam intensity and purity were measured using the 
standard delta-E/Time-of-Flight technique with a silicon-PIN diode in the A1900 focal plane and 
cyclotron RF signal prior to delivery of the beam to the experimental end station.16  The 
secondary beam was collected for four hours in the liquid water target system before being 
transferred to a collection vessel.  Four additional collections, each lasting four hours, were made 
before shipping samples to Washington University and Hope College for chemical separation 
and analysis. 
Table 4-1.  Experimental parameters for the 67Cu secondary beam at the NSCL. 
Block Description Value 
Primary Beam Target Beryllium 510.797 mg/cm2 
D1 Bρ Dipole magnet 3.2822 Tm 
I1 Slits Momentum acceptance (dρ/ρ) 2.03% 
D2 Bρ Dipole magnet 3.2822 Tm 
I2 Slits Momentum acceptance (dρ/ρ) 2% 
I2 Wedge Aluminum 236.685 mg/cm2 
D3 Bρ Dipole magnet 2.9147 Tm 
D4 Bρ Dipole magnet 2.9147 Tm 
CRAD06 BC-400 scintillator (removable) 155 µm 
D5 Bρ Dipole steering magnet 2.9027 Tm 
D6 Bρ Dipole steering magnet 2.9027 Tm 
Exit Window Zirconium 75 µm 
Air Gap Air 89 mm 
Water Target Window Kapton 8 µm 
Water Target H2O 73 mm 
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At the NSCL there are several non-intercepting beam monitors, Faraday cups, and a BC-
400 plastic scintillator that can be used to measure beam current.  The Faraday cups and 
scintillator can be used to determine particles per second, however, only the non-intercepting 
beam monitors can be used to measure the beam at full intensity during the sample collections.  
Calibration curves had to be established comparing the non-intercepting beam monitors with the 
Faraday cups and scintillators in order to calculate particles per second delivered to the water 
target station.  Two calibrations of the beam monitors were performed during which the beam 
was attenuated by 10-1 to 10-3 times the full beam intensity.  The currents from Faraday-cups, 
non-intercepting beam monitors, and the count rates from the scintillators were recorded and 
used to construct linear calibration curves.  An aliquot from each of the five water samples was 
analyzed with an HPGe detector to determine the amount of 67Cu present in the sample and 
decay corrected to the end-of-bombardment in order to determine the beam transport efficiency.    
 
Separations Involving Chelating Disk 
All separations using the high-performance extraction disk (3M Empore, MN) were 
carried out with 100mL 1.25M ammonium acetate (trace metals grade) and pH adjusted to 5 by 
adding acetic acid (trace metals grade).  The high-performance extraction disk is functionalized 
with iminodiacetic acid groups and at pH 5 the carboxylate groups are negatively charged and 
will bind to metal cations.  The solution was then drawn through a 25mm diameter extraction 
disk in a glass microanalysis vacuum filter holder (Millipore, MA) with vacuum, after the disk 
was pretreated by rinsing with 20mL milli-Q water, 20mL 3M nitric acid (trace metals grade), 2-
50mL milli-Q water, 50mL 0.1M ammonium acetate, followed by two additional rinses of 25mL 
milli-Q water, allowing the disk to dry between each rinse.  When passing the 100mL sample 
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through the extraction disk, a new vacuum flask was used to save the eluent so that it could be 
analyzed by HPGe detector for radioactivity that did not bind to the extraction disk.        
 
Germanium Separation Validation 
Several concentrations of aqueous germanium ranging from 0.04-0.5 ppm in 1.25 M 
ammonium acetate were passed through the extraction disk using the method described above.  
The chelation disk was analyzed using particle-induced x-ray emission (PIXE) by irradiating the 
chelation disk with 3.4 MeV protons for five minutes at beam intensities between 2.25-2.80 nA.  
A Si(Li) detector was used to measure the resulting x-rays.  The characteristic Kα x-rays for 
germanium were analyzed to determine the amount of germanium bound to the chelation disk. 
 
68Ga and 64Cu Separation Validation 
200µCi of 68Ga obtained from a 68Ge/68Ga generator and 200µCi of 64Cu produced at 
Washington University in St. Louis were added to 100mL of 1.25M ammonium acetate and 
passed through the extraction disk using the method given above.  The extraction disk was 
surveyed by HPGe for 68Ga and 64Cu using the characteristic gamma rays, 1077.3keV (3.22%) 
for 68Ga and 1345.8keV (0.475%) for 64Cu.  The extraction disk was returned to the filter holder 
and 10mL of 6M hydrochloric acid (trace metals grade) was added to remove 64Cu from the 
extraction disk.  Both the extraction disk and the filtrate were analyzed by HPGe to measure 
amounts of 68Ga and 64Cu present in each.     
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Copper, Nickel, and Zinc Separation Validation 
Aqueous solutions containing 100µg of copper, nickel and zinc (1000mg/L AAS 
Standards, Sigma Aldrich, USA) were added to 100mL 0.1M ammonium acetate solution at pH 
5.5 and passed through the chelation disk as described above.  10mL of 6M hydrochloric acid 
(trace metals grade) was then added to remove the nickel, copper, and zinc that were bound to 
the chelation disk.  This solution was then passed through an anion-exchange column containing 
2.5g AG1-8X resin (Bio-Rad, USA) and washed with an additional 10mL of 6M HCl to remove 
the nickel followed by 10mL of 0.5M HCl to remove the copper.  Each 10mL fraction was 
brought to dryness by evaporation through overnight heating at 80ºC and reconstituted in 1mL 
Ultratrace water (Sigma Aldrich, USA) and analyzed by an HPLC trace metal ion 
chromatography method.17 
 
67Cu Separation 
First, each 100mL sample was adjusted to 1.25M solution of NH4OAc by adding 9.6g 
trace metals grade ammonium acetate and pH adjusted to 5 by adding trace metals grade acetic 
acid.  The ~100mL solution was then passed through the chelation disk as described above.  The 
filter holder was transferred to a clean vacuum flask and 10mL of 6M trace metal grade 
hydrochloric acid was passed through to remove the 67Cu along with the nickel and zinc 
contaminants.  The 6M HCl elution was then transferred to an anion-exchange column with 
AG1-X8 resin, the 10mL eluate was collected and then an additional 10mL of 6M hydrochloric 
acid was passed through the column and collected.  Finally 10mL 0.5M hydrochloric acid was 
added to the resin and 1mL fractions of the eluate were collected.  All eluates were analyzed for 
radiochemical purity by observing the characteristic gamma rays in an HPGe detector.         
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67Cu-NOTA-Trastuzumab Labelling 
A 10mg/mL stock of NOTA-NCS was made by dissolving 3.66mg NOTA-NCS 
(Macrocyclics, USA) in 366uL Dimethyl sulfoxide.  50uL of 21ug/uL Trastuzumab (Genentech, 
USA) was added to 4uL NOTA-NCS stock solution and 96uL 0.1M sodium carbonate pH 9.0 
and incubated for 1hr at 37C on a shaking incubator.  A Zeba spin desalting column (40kDa 
cutoff, 0.5mL) was used to buffer exchange the conjugate into 0.1M ammonium acetate buffer at 
pH 5.5.  Concentration of the NOTA-Bz-NCS-Trastuzumab was measured using the 
bicinchoninic acid (BCA) assay. 
The two 1mL 0.5M hydrochloric acid samples with the largest amounts of 67Cu were 
brought to dryness and reconstituted using 50uL of 0.1M ammonium acetate at pH 5.5.  5uL was 
transferred to a new tube and 5uL 50mmol EDTA was added.  The remaining 45uL was added to 
a microfuge tube along with 2uL NOTA-Bz-NCS-Trastuzumab and brought to 50uL by adding 
0.1M ammonium acetate at pH5.5.  Tubes were placed in a shaking incubator at 37ºC for twenty 
minutes.  This method was adapted from one previously reported by Ferreira et al.18  The 
solution containing 67Cu-NOTA-Bz-NCS-Trastuzumab was then challenged with 1μL 50mmol 
EDTA.  1uL from each tube was spotted on ITLC paper (Agilent, ) at 2cm from the bottom of 
the paper and  placed in 1cm running buffer (1:1 10% ammonium acetate and methanol) and ran 
until the eluent was 5cm past the starting point (7cm total).  The paper was then analyzed by 
radio TLC scanner.   
  
 7Be Cross Section Analysis 
After allowing the short-lived isotopes to decay, the 100mL eluent from the chelation 
disk was analyzed for presence of 7Be using HPGe analysis of the 477 keV gamma ray (10.44%) 
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present in spectra collected for 12 and 24 hours.  The counts were decay corrected back to the 
end of each collection run.  
 
Results 
Beam Calibration and Collection 
A 76 MeV/A 67Cu secondary beam of 77% purity was selected from a fragmented 76Ge 
primary beam using the A1900 fragment separator16 and delivered to the S1 vault where the 
water target station was set up to collect the incoming beam.  In order to quantify the amount of 
67Cu delivered to the target, calibration curves were developed to convert the signals from the 
non-intercepting beam monitors that were continuously operating during beam collections and 
the fully-intercepting Faraday-cups or scintillators that could not be in place during the sample 
collections.     
Two separate calibration methods were used to determine the number of beam particles 
delivered to the water target station during two calibration runs performed approximately 12 
hours apart.  One calibration run was prior to most of the collections and the other was post most 
of the collections.  In the first method a calibration curve was established to normalize the 
proportional data from the non-intercepting beam monitors (Monitors A and B in Figure 4-3) to 
the direct measurements of the primary beam current (in nA) with a Faraday cup.  The 
proportional rates from A and B were integrated over the course of each run and then multiplied 
by the conversion factor of 4.1 ± 0.2 x 105 67Cu ions per second per particle-nA of primary beam 
(determined by the A1900 operations group) to give the rate of 67Cu atoms delivered.  The 
second method established calibration curves of two non-intercepting beam monitors A and B 
with the focal-plane plastic scintillator that was used to measure the rate of secondary beam 
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arriving at the A1900 focal plane in particles per second, and these values were integrated over 
the course of each run and multiplied by the purity factor of 77% to obtain the total atoms of 
67Cu delivered to the beam stop.  Due to the different working ranges of the detectors used to 
measure the beam current, two separate calibration curves had to be used.  The first curve 
converted the high-intensity beam measured with the non-intercepting beam monitors A and B to 
 
Figure 4-3:  The results of the calibration performed with Method 2 are shown in panels: (A) 
Beam Monitor A vs Beam Monitor C, (B) Beam Monitor B vs Beam Monitor C, and (C) 
Beam Monitor C vs Scintillator.  The results of the calibration performed with Method 1 are 
shown in panels: (D) Beam Monitor A vs Faraday-Cup and (E) Beam Monitor B vs Faraday-
Cup. 
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a medium intensity non-intercepting beam monitor C and the second curve converted the 
medium intensity non-intercepting beam monitor C to the low intensity focal-plane scintillator 
values in particles per second.  The data for both methods for the second calibration run carried 
out post-collection are shown in Figure 4-3.  Linear functions were found to provide excellent 
descriptions of all of the data. 
Five collections were performed, each lasting approximately four hours, and the water 
from each run was collected as an individual sample for each run. The numbers of 67Cu ions 
delivered to the liquid water target system in each run, calculated using the two methods, along 
with the values obtained by measuring the gamma-ray activity for aliquots taken from the 
samples using an HPGe detector are listed in Table 4-2.  The values obtained from the two 
calibration curves were averaged for beam monitor A and B in both methods.  The average 
transport efficiency of the 67Cu secondary beam into the liquid water target system from the 
A1900 separator to the water target system was found to be 84 ± 5 %.  The modest intensity 
reduction occurred between the focal plane and the end station or on the collimator immediately 
in front of the water target station entrance window.   
Table 4-2:  Beam delivered to the water target station calculated using beam monitor A or B 
averaging the data from the prior and post collection calibration curves compared to the amount 
measured in the water using an HPGe detector. 
 
Method Run 1(kBq) Run 2(kBq) Run 3(kBq) Run 4(kBq) Run 5(kBq) 
1 A 552 (31) 551 (31) 521 (30) 512 (29) 524 (30) 
1 B 527 (31)  527 (31) 503 (29) 493 (28) 500 (29) 
2 A 524 (24) 523 (24) 494 (22) 485 (22) 497 (23) 
2 B 501 (29) 501 (29) 478 (28) 469 (28) 476 (28) 
Average 526 (29) 525 (29) 499 (27) 490 (27) 499 (28) 
HPGe 460 (9) 452 (9) 425 (8) 403 (8) 397 (8) 
Transport 
efficiency 
87 (5) 86 (5) 85 (5) 82 (5) 80 (4) 
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Chemistry 
To plan the chemical separation procedure, modeling of the radioisotopes delivered to the 
water cell and their decay products was carried out using the LISE++ code with the EPAX3 
cross sections and the Nucleonica© decay engine, respectively, as was carried out for the 
previous 24Na work.8  The theoretical beam components with half-lives greater than one minute 
predicted by the LISE++ code to enter the target water are given in Table 4-3.  Note that the 
projectile fragment separator tends to deliver more isotonic (same number of neutrons) than 
isotopic (same number of protons) contaminants and the primary beam is completely removed.   
Table 4-3.  Predicted secondary beam components with half-lives greater than one minute. 
 
Nuclide Half-life Particles/s 
67Cu 2.58d 7.33E6  (79.3%) 
66Ni 2.28d 2.93E5  (  3.2%) 
65Ni 2.52h 1.42E5  ( 1.5%) 
69Zn 56m 1.25E6  (13.5%) 
70Ga 21.14m 1.01E3  (  0.1%) 
68Zn Stable 2.30E5   ( 2.5%) 
   
All of the different metals were effectively separated from the 67Cu collections using the 
methods described below.  The chemical separation relied on absorption of the positively 
charged cations to a metal-chelation disk, elution, and separation by anion-exchange 
chromatography.  All methods were validated prior to the 67Cu separations using either non-
radioactive species or radioactive surrogate species as tracers.  An experiment measuring the 
efficiency of removing germanium (primary beam) contamination that would be present in the 
primary beam dump in future work at FRIB was determined using PIXE (Particle Induced X-ray 
Emission) analysis of 0.04-0.5 ppm germanium that was passed through the chelating disk.  The 
results showed average germanium retention of only 2.7 ± 0.9 %.  This is likely due to the 
formation of the neutral compound Ge(OH)4 at pH 5
19 that did not bind to the negatively charged 
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carboxylate groups.  In order to test the separation strategy for copper and gallium, 68Ga (t
1/2
=68 
min) obtained from a 68Ge/68Ga generator (Eckert and Ziegler, Germany) and 64Cu (t
1/2
=12.7 h) 
produced at Washington University in St. Louis20 were used as radioactive tracers.  Passage of 
68Ga and 64Cu solutions through the chelation disk found that both metals remained bound within 
the disk with greater than 99% efficiency; however, 10 mL of 6 M HCl was able to elute, 98 ± 1 
% of 64Cu from the disk, while 97 ± 2 % of 68Ga remained fixed to the disk.  This is due to Ga3+ 
having a greater affinity for the chelation disk than Cu2+ and thus Ga3+ would require a higher 
chloride concentration to elute.  Subsequent separation of copper from zinc and nickel was 
obtained using anion-exchange chromatography and verified by ion chromatography.17  The 
percent of the initial nickel and zinc concentrations were found to be 4 ± 2 % and 6 ± 4 %, 
respectively in the 0.5M HCl fraction.  The average copper recovery from this method was 
shown to be 86 ± 4%.  The resulting separation process is shown schematically in Figure 4-4. 
 
Figure 4-4:  Flow chart indicating the separation strategy to recover 67Cu from the aqueous 
samples containing 67Cu projectile fragments collected at the NSCL. 
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Four of the 67Cu samples were shipped to Washington University in St. Louis and 
processed as described above.  Table 4-4 contains the values for the recovery of 67Cu from the 
aqueous solutions containing the projectile fragments from the NSCL.  The average recovery of 
67Cu was found to be 88 ± 3 %, a value in excellent agreement with the tracer studies.  The 
separated (final) 67Cu fractions were analyzed using an HPGe detector (Canberra, USA) 
calibrated using a 2mL mixed source (Eckert and Ziegler, Germany) and no radioactive 
impurities were observed.  The gallium species had completely decayed from the sample before 
processing due to its short half-life and the decontamination factors for nickel and zinc were 20 
and 12.5 respectively.   
Table 4-4.  Chemical recovery of 67Cu from the aqueous solutions produced at the NSCL. 
 
 Run2(kBq) Run3(kBq) Run4(kBq) 
Starting Activity 452 (9) 425 (8) 403 (8) 
Recovered Activity 388 (8) 380 (8) 353 (7) 
Percent Recovery 86 (2) 89 (3) 88 (2) 
 
Test labeling of an antibody, Trastuzumab, was performed to demonstrate that 67Cu 
separated from the water beam dump would be chemically active.  Bicinchoninic acid (BCA) 
assay showed the final concentration of the conjugated NOTA-Bz-NCS-Trastuzumab to be 
7.9mg/mL.  The radiochemical yield of 67Cu-NOTA-Bz-NCS-Trastuzumab of 0.5μCi/ug was 
found to be greater than 95% by radio instant thin-layer chromatography (ITLC).  Figure 4-5 
shows the results of fast-protein liquid chromatography of NOTA-Bz-NCS-Trastuzumab, radio 
ITLC of 67Cu-NOTA-Bz-NCS-Trastuzumab, radio ITLC of 67Cu-EDTA along with an 
illustration of the NOTA chelate bound to Trastuzumab. 
 
 
 
75 
 
 
 
 
 
 
  
 
 
 
 
Figure 4-5:  (A) Structure of the NOTA-Bz-NCS conjugated to lysine residues on 
Trastuzumab.  (B) Fast Protein Liquid Chromatography of NOTA-Bz-NCS-Trastuzumab 
indicating an intact conjugated antibody.  (C) Radio instant thin layer chromatography of 
67Cu-NOTA-Bz-NCS-Trastuzumab challenged with EDTA.  The sharp peak at 60mm and the 
absence of a later peak signifies a fully labeled antibody. (D) Radio instant thin layer 
chromatography of 67Cu-EDTA which serves as a negative control.   
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The production of 7Be from reactions of beam on water 
One concern with using an aqueous beam dump to collect high-energy fragments is the 
buildup of long-lived radioactivity from nuclear reactions with the water.  7Be (t
1/2
=53.3 d) is 
produced in reactions between essentially all fast ion beams and water.  While 7Be can be easily 
separated from the 67Cu in this experiment, there may be instances where this contaminant could 
interfere with the harvesting process. The predicted production rate of 7Be with an incident 
medium mass beam (A≈67) is 6.4 x 10-4/incident ion.15  The 7Be concentrations in the present 
samples were measured using HPGe spectroscopy and showed that the production of 7Be per 
incident ion on water was 5 ± 2 x 10-4.   
In addition to 7Be, 11C and 13N were observed byproducts of the interaction of the 
secondary beam on water.  Due to the short half-life of these isotopes, they were not observed on 
the HPGe detector, however their decay was observed using a CsF detector that monitored the 
collection vials upon completion of a four-hour collection.  Future experiments will be designed 
in order to quantify the amount of these short-lived byproducts that are produced. 
   
Discussion 
A liquid water target station previously designed to collect fast, secondary beams from 
the National Superconducting Cyclotron Laboratory was used to collect five samples of 67Cu.  
The five collections lasted for four hours each, and the samples were then shipped to Hope 
College and Washington University in St. Louis for further analysis and chemical separation.  
67Cu was effectively separated from the beam contaminants with an average recovery of 88 ± 3 
%.  The resulting 67Cu was then bound to NOTA-Bz-NCS-Trastuzumab with a radiochemical 
yield of >95%.  These results demonstrate the feasibility of harvesting useful radioisotopes from 
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the aqueous beam dump at the Facility for Rare Isotope Beams (FRIB) now under construction at 
Michigan State University.  Future experiments will be performed to collect and separate 67Cu 
from an unanalyzed, i.e., mixed secondary beam to better mimic the conditions that would be 
present in the actual FRIB beam dump.   
The overall production of 67Cu at the NSCL was estimated to be 7.33 x 106 pps for the 
76Ge beam and experimental conditions reported here16. An observed rate of 1.13 x 107 pps of 
67Cu was measured during this experiment which closely matches the predicted yield for the 
NSCL. Since the same codes are used to estimate yields at FRIB, this bodes well for an expected 
production rate of ~2Ci of 67Cu in the primary beam dump at saturation during regular 
operations. Similarly the production of 7Be was also measured to be 5.7 x 103 pps, which also 
compare favorably with the predicted production rate of 4.7 x 103 pps. 
While this proof-of-principle experiment made use of a water target cell to collect the 
beam in a small volume of non-circulating water, in the future at the Facility for Rare Isotope 
Beams there will be ion exchangers present which could act as potential sources for isotope 
harvesting.   Additional research will be needed in order to determine how much 67Cu (and other 
isotopes of interest) can be extracted from the resin for the purposes of isotope harvesting.   
The most promising radionuclides for isotope harvesting from FRIB would be those 
which cannot be produced easily by other means, such as with a reactor or small medical 
cyclotron.  Additionally, isotope availability may depend on the needs of the primary user, how 
pure the isotopes need to be and the frequency of production.   While this is a very promising 
source of isotopes for many fields, it should be noted that isotopes obtained in this manner will 
not be available continuously due to an incompatibility with the primary beam requirements.  
Thus, due to the nature of this technique, it is likely that medium- to long-lived research isotopes, 
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like the one studied here, will be the most promising targets for isotope harvesting from heavy-
ion fragmentation facilities. 
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Chapter 5 
 
Harvesting 67Cu from the Collection of an Unanalyzed Secondary Beam at the National 
Superconducting Cyclotron Laboratory 
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Introduction 
 The collection of the analyzed 67Cu secondary beam at the NSCL, discussed in Chapter 4, 
was an idealized case.  The separation from numerous beam contaminants must be performed to 
better address the feasibility of harvesting 67Cu from an aqueous beam dump.  The fragment 
separator at the FRIB facility1,2 will operate similarly to the A1900 at the NSCL.3  The 
fragmented primary beam will travel through a dipole magnet to remove the primary beam and 
the fragmented isotopes that differ in magnetic rigidity from the isotope of interest to the end 
user.  At the FRIB facility the discarded isotopes will go into an aqueous beam dump.  Because 
an aqueous beam dump does not currently exist at the NSCL the normal beam separation process 
must be manipulated to obtain an impure (unanalyzed) secondary beam.       
The aluminum wedge in the A1900 (Figure 5-1)3 is an important part of the beam 
purification process.  Several different isotopes will have a similar magnetic rigidity to the one 
selected for the isotope of interest after the fragmentation process, however they will differ in 
charge.  The energy of the ions is reduced as they transfer energy to the electrons in the medium 
 
Figure 5-1.  Schematic of the A1900 fragment separator at the NSCL.3  The aluminum 
wedge is shown.   
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(this energy loss is well described by the Bethe-Bloch equation).  This loss of energy changes 
each ion’s momentum and its magnetic rigidity (the reduction in magnetic rigidity is proportional 
to the momentum change if the charge state is not changed).  At the energies of the present work, 
the ions are fully stripped so the charge, Q, is equal to the atomic number, Z.  The beam is 
usually purified by passing it through another set of dipoles set to pass the rigidity of the isotope 
of interest after it passes though the wedge absorber.  An unanalyzed beam can be obtained by 
removing the aluminum wedge.  Collection of this unanalyzed secondary beam using the water 
target station, discussed in Chapter 3, is a better representation of the conditions that would be 
present in the beam dump at FRIB.4          
Previously, we were able to separate 67Cu from nickel, zinc, germanium, and gallium 
collected from an analyzed secondary beam using a two-part chemical purification process.  A 
more complicated procedure had to be developed for separation of 67Cu from the unanalyzed 
beam, which consisted primarily of first-row transition metals.  Most of the elements present in 
the secondary beam consisted of one or more radioactive isotopes.  Characteristic gamma rays 
for each radioisotope were analyzed to monitor the separation of 67Cu from the different 
elements, which ranged in atomic number from 19 to 34.  
Three separate collections were obtained and shipped to Washington University in St. 
Louis for chemical separation and gamma analysis.  67Cu was chemically separated from the 
beam contaminants with high radiochemical purity and used to radiolabel an anti-EGFR antibody 
(Panitumumab).5   Biodistribution studies were conducted with this radiopharmaceutical using 
colon cancer xenografts to demonstrate proof of concept.     
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Materials and Methods 
Beam Collection  
In a similar manner to the method discussed in Chapter 4, a 25 particle-nA 130 MeV/u 
76Ge beam was fragmented using a 493 mg/cm2 thick beryllium production target in the A1900 
projectile-fragment separator.3  The aluminum wedge was removed from the center of the A1900 
to obtain an unanalyzed secondary beam.  The focal plane (FP) mass-selection aperture was set 
to 10 mm and the momentum acceptance slits open to 2% (full momentum acceptance).  The 
experimental parameters for the separator and beam line are listed in Table 5-1.  Note that the 
two sets of dipoles D1-D2 and D3-D4 are set of the same rigidity. This arrangement passes 92.9 
MeV/u 67Cu29+, which corresponds to a momentum of 28.5 GeV/c, and other ions with different 
momenta but the same rigidity. The slits fix the range of momenta that are passed to ± 2% of 
value of each ion that corresponds to a Brho = 3.2822 Tm.  The beam intensity and purity were 
measured using the standard delta-E/Time-of-Flight technique with a silicon-PIN diode in the 
A1900 focal plane and cyclotron RF signal prior to delivery of the beam to the experimental end 
station.3   
Table 5-1.  Experimental parameters for the 67Cu secondary beam at the NSCL. 
Block Description Value 
Primary Beam Target Beryllium 493 mg/cm2 
D1 Bρ Dipole magnet 3.2822 Tm 
I1 Slits Momentum acceptance (dρ/ρ) 2.03% 
D2 Bρ Dipole magnet 3.2822 Tm 
I2 Slits Momentum acceptance (dρ/ρ) 2% 
D3 Bρ Dipole magnet 3.2822 Tm 
D4 Bρ Dipole magnet 3.2822 Tm 
D5 Bρ Dipole steering magnet 3.2822 Tm 
D6 Bρ Dipole steering magnet 3.2822 Tm 
Exit Window Zirconium 75 µm 
Air Gap Air 89 mm 
Water Target Window Tantalum 12.7 µm 
Water Target H2O 73 mm 
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Three separate collections of the secondary beam were made using the water target 
system as described in Chapter 3 with two modifications.  Due to the higher intensity of the 
beam compared to previous experiments, a 12.7 μm tantalum foil was used in place of the 8μm 
kapton film.  Additionally, room temperature water was circulated through the water target cell 
at 100 mL/min via a Teflon tube, to keep the collection water below 30ºC.   
 
Beam Current and Collection Efficiency  
Several carbon disks (1.245” in diameter and 0.4” thick) were used to collect the 
incoming beam at various times throughout the experiment.  A rotating wheel with 12 holes 
1.25” in diameter, containing the carbon disks in alternating positions, was placed between the 
zirconium exit window and the entrance window to the water target station.  The rotating wheel 
could be controlled remotely from outside of the experimental vault.  A position consisting of an 
empty hole was used during aqueous beam collection.  At various times during the experiment, 
the wheel was rotated so that one of the carbon disks was in line with the entrance window.  The 
secondary beam was collected by the carbon disk for 2-5 minutes before returning the wheel to 
an empty position.  The carbon disks were shipped to Hope College for gamma analysis using an 
HPGe detector to obtain a beam current (67Cu atoms/second).   
The beam current was measured by several non-intercepting beam monitors located 
throughout the A1900.3  Because the non-intercepting beam monitors measured an intensity that 
was proportional to the beam current and not the actual beam current, a calibration factor had to 
be obtained to relate the two parameters.  The intensity measured by the beam monitors was 
averaged for the time interval corresponding to the respective carbon disk irradiation.  The 
calibration factor was obtained by dividing the measured 67Cu atoms per second by the average 
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intensity measured by the beam monitors.  To calculate the total amount of 67Cu delivered to the 
water target station, the beam intensities measured throughout the experiment using the non-
intercepting beam monitors were integrated over the total time of collection and multiplied by 
the calibration factor.  The 67Cu beam collection efficiency was calculated as the total number of 
67Cu atoms collected, as measured by HPGe, divided by the total number of 67Cu atoms 
delivered. 
 
Preliminary Separation Experiments 
 The first step in developing a separation strategy was to monitor where cobalt, iron, and 
manganese appeared in the separation strategy used in Chapter 4.  10 μg of Cu, Zn, Ni, Co, Fe, 
and Mn were added to 100 mL of 1.25 M NH4OAc pH 5 and passed through a chelation disk as 
described previously.  At pH 5 the carboxylate functional groups on the chelation disk are 
negatively charged, thus attracting positively charged ions.  The metal ions in the above solution 
existed as 2+ ions with the exception of manganese, which likely existed as both a 2+ ion and as a 
MnO molecule.  The addition of 10 mL 6 M HCl to the chelation disk extracted the 2+ metals 
that were chelated by the disk without removing the 3+ metals from the disk.  Following passage 
through the chelation disk the 6M HCl fraction was added to an anion exchange column 
containing 2.5g of AG1-X8 resin (Bio-Rad, CA).  The elution constants of these metals for 
quaternary amine functionalized resin vary with the concentration of hydrochloric acid.6  
Varying amounts of 6M, 4M, 2.5M and 0.5M HCl were used to elute the different metallic ions 
from the anion exchange resin.  Each fraction collected was evaporated to dryness and 
reconstituted in 5 mL of 3% HNO3 (the metallic ions existed as Cu
2+, Ni2+, Zn2+, Co2+, Mn2+, 
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Fe2+).  An aliquot of each fraction was diluted by a factor of 500 and measured via Ion 
Chromatography7 to monitor the separation of the different elements.   
 The separation of cobalt from copper was more difficult than with the other divalent 
metals because the elution constants of these two metals are similar.6  Because the elution 
constant for cobalt rises at a steeper rate than that of copper between 6M and 3M hydrochloric 
acid, we varied the concentration of HCl in this range monitoring the copper-cobalt separation 
with the radiotracers 55Co and 64Cu.  3.7 MBq of 55Co and 64Cu in 10 mL of 6M HCl were added 
to an anion exchange column with 2.5g of AG1-X8 resin and the eluate was collected.  Three 
additional fractions of 10 mL of 6M HCl were added to the resin and their eluate was collected.  
10 mL of 4M HCl were added to the resin and the eluate was collected.  Then, 10 mL of 2.5M 
HCl were added to the resin and the eluate was collected.  Finally, 10 mL of 0.5M HCl were 
added to the resin and the eluate was collected.  The eluate from each fraction was analyzed by 
an HPGe detector to detect the characteristic gamma rays of 64Cu (1345 keV) and 55Co (931, 
477, and 1408 keV). 
 The chemistry of vanadium is much more complex than the metals described above and it 
is likely that vanadium deposited in the aqueous beam dump will exist in several different charge 
states.  The ion chromatography method cannot be used to measure the concentration of 
vanadium, therefore another method had to be developed to monitor the separation of vanadium.  
Vanadium was oxidized to the +5 oxidation state by the addition of hydrogen peroxide.  A UV-
Vis spectrophotometer at 450nm was used to obtain an absorbance for this solution.  Calibration 
curves for vanadium in 6M, 2.5M, and 0.5M hydrochloric acid were obtained for concentrations 
ranging from 2mg/L to 12mg/L using an atomic absorbance standard of vanadium.  Linear 
calibration curves were achieved.   
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 A 100 mL 1mg/L solution of vanadium in 1.25M NH4OAc pH 5 was passed through a 
chelation disk.  10 mL of 6M HCl were then passed through the disk and collected.  20μL of 
H2O2 were added to a 1 mL aliquot of the eluate and its absorbance measured at 450nm.  The 
remaining 9 mL of 6M HCl were added to a column containing 2.5g AG1-8X resin.  Two 
additional 10 mL 6M HCl fractions followed by a 10 mL 2.5M fraction were eluted from the 
column and 20μL of H2O2 were added to 1mL aliquots from each fraction and their absorbance 
measured at 450nm the absorbance peak for V(V) complexes. 
 Titanium in an aqueous solution is readily oxidized to TiO2, which is insoluble in water.  
However, the concentration of titanium will be very low in the beam dump, therefore it is 
expected that TiO2 will be soluble at this concentration.  As with vanadium, titanium 
concentration cannot be measured using ion chromatography.  However in acidic medium and in 
the presence of hydrogen peroxide titanium exhibits a bright yellow color representative of its +4 
oxidation state.  Calibration curves were made in 6M, 2.5M, and 0.5M HCl for concentrations 
ranging from 2mg/L to 12mg/L.  Linear curves were obtained as the plot of absorbance at 405nm 
vs concentration.   
An atomic absorption standard of TiO2 was used to make a 100mL 1mg/L solution of 
titanium in 1.25M NH4OAc at pH 5.  This was passed through a chelation disk followed by 10 
mL 6M HCl.  A 1mL aliquot of the 6M HCl eluate was collected and 20μL H2O2 were added.  
The absorbance was measured at 405nm.  The remaining 9mL of 6M HCl were subjected to 
anion exchange chromatography in the same manner as described for vanadium.  20μL H2O2 
were added to a 1mL aliquot from each fraction and their absorbance measured at 405nm the 
absorbance peak for Ti(IV) complexes.           
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67Cu Separation 
First, each 100mL collection was adjusted to 1.25M solution of NH4OAc by adding 9.6g 
trace metals grade ammonium acetate and pH adjusted to 5 by adding ~3mL trace metals grade 
acetic acid.  The ~100mL solution was then passed through the chelation disk as described in 
Chapter 4.  The filter holder was transferred to a clean vacuum flask and 10mL of 6M trace 
metal grade hydrochloric acid were passed through to remove the 67Cu and other 2+ metal 
contaminants bound to the chelation disk.  The 6M HCl elution was then transferred to an anion-
exchange column with AG1-X8 resin, the 10mL eluate was collected and then two additional 
10mL fractions of 6M hydrochloric acid were passed through the column and collected.  Next 
10mL 2.5M hydrochloric acid were added to the resin and the eluate was collected.  Then 10mL 
0.5M HCl were added to the resin and the eluate collected.  All eluates were analyzed for 
radiochemical purity by observing the characteristic gamma rays in an HPGe detector.       
 
Conjugation of NOTA-Bz-NCS to Panitumumab  
A 10mg/mL stock solution of NOTA-Bz-NCS was made by dissolving 4.18mg NOTA-
Bz-NCS (Macrocyclics, USA) in 418μL of 0.1M sodium carbonate buffer (pH9).  50μL of 
20μg/μL Panitumumab (Genentech, USA) were added to 10μL NOTA-Bz-NCS stock solution 
followed by the addition of 50μL of 0.1M sodium carbonate buffer (pH 9.0) and incubated at 
37ºC for 1 hr in a shaking incubator.  A Zeba spin desalting column (40K MWCO, 0.5mL) was 
used to buffer exchange the conjugate into 0.1M ammonium acetate buffer (pH 5.5). The 
concentration of the NOTA-Bz-NCS-Panitumumab conjugate was measured using the Bradford 
assay.8 
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Evaluation of Immunoreactivity 
The immunoreactivity of the conjugated NOTA-Bz-NCS-Panitumumab was measured to 
verify that the conjugation did not affect the antigen-binding properties of the antibody.  This 
was done by incubating different concentrations of 64Cu-NOTA-Bz-NCS-Panitumumab with a 
fixed number of antigens (cells).  Method 3 as described by Konishi et al9 was used to measure 
the immunoreactive fraction (IF) of the radiolabeled antibody.  The final effective specific 
activity of 64Cu-NOTA-Bz-Panitumumab was 185 kBq/μg.  Radiolabeling was confirmed to be 
>99% by radio thin-layer chromatography as described in Chapter 4.  The radiolabelled 
Panitumumab was brought to a final concentration of 4.18 μg/mL in 0.1M NH4OAc pH 5.5.  
Serial dilutions were performed so that solutions ranging from 0.0625 μg/mL through 4.18 
μg/mL were obtained.  50μL of each concentration was added to 500μL of 3 x 106 HCT-116 
cells suspensions containing 0.1% bovine serum albumin in PBS, in triplicate.  Cell solutions 
were placed on a shaker at room temperature and incubated for 2 hours.  Cells were pelleted at 
1,000 x g for 3 minutes and the supernatant was removed.  Cells were then washed three times 
with 500μL of phosphate buffered saline, pelleting and removing the supernatant between each 
wash.  Standards containing the initial activity of each concentration along with the cell pellets 
were counted on a gamma counter.  The immunoreactive fraction was calculated using equation 
8 (Equation 5-1) as described by Konishi et al9 where B is bound antibody, T is total antibody, 
Fmax is the maximum number of binding sites, r is the immunoreactive fraction, and Ka is the 
association constant.  The ratio of bound vs. total antibody was graphed against the total 
antibody (pmol) in Prism 6 (Graphpad, California).  Fmax, r, and Ka were used as the fitting 
parameters in order to obtain a best fit curve.     
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Animal Models 
All animal care was performed as stated in the Guide for Care and Use for Laboratory 
Animals by the National Institutes of Health under a protocol approved by the Animal Studies 
Committee at Washington University in St. Louis.  Female Athymic Nu/Nu mice (National 
Cancer Institute, USA) aged 6-9 weeks were anesthetized with a ketamine/xylazine cocktail 
(VEDCO, USA).  100 μL of approximately 3 x 107 cell/mL HCT-116 colon cancer cells 
suspended in saline were subcutaneously injected into the shoulder.  Tumors were allowed to 
grow for two weeks before biodistribution studies. 
 
Radiolabeling and Biodistribution of 67Cu-NOTA-Bz-Panitumumab 
 The 2.5M HCl fractions from the three separations were mixed together, brought to 
dryness, and reconstituted in 30μL of 0.1M HCl (67Cu existed as 67Cu2+).  25μL (451 kBq) of 
67Cu was added to 25μL of 0.5M NH4OAc and the final solution had a pH of 5.5 (at pH 5.5 the 
carboxylate groups on NOTA are negatively charged allowing Cu2+ to be chelated).  111 μL 
5.5mg/mL NOTA-Bz-Panitumumab was added to the mixture and incubated at 37ºC for 30 
minutes.  Radiolabeling was confirmed using radio thin-layer chromatography.  The solution was 
brought to 400μL by the addition of saline and non-specifically bound 67Cu was challenged with 
EDTA (final EDTA concentration of 1mM).   
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 113 kBq of 67Cu-NOTA-bz-Panitumumab was injected into three HCT-116 colon cancer 
xenografted mice via the tail vein.  Biodistribution studies were performed at five days post 
injection. Organs and tumors were harvested and weighed. The radioactivity associated with 
each organ was assayed in a gamma counter, background and decay corrected, to determine the 
percentage of injected dose per gram of organ (%ID/g).  
Results 
Beam Collection 
 A 76 MeV/u unanalyzed 67Cu secondary beam with a purity of 2.6% was selected from a 
fragmented 76Ge primary beam and delivered to the S1 vault where the water target station was 
set up to collect the incoming beam.  The average calibration factors measured for Beam 
Monitors A and B were 2.6 ± 0.5 x 109 and 6 ± 1 x 1012 respectively.   The data from each of the 
irradiated carbon disks is listed in Table 5-2.   
Table 5-2.  Beam Current data obtained from irradiation of the carbon disks. 
Sample 
Total 67Cu 
Atoms 
Collection 
Time (s) 67Cu atoms/s 
Beam 
Monitor A 
Calibration 
Factor 
Beam 
Monitor B 
Calibration 
Factor 
Disk 1 1.41 (0.03) x 109 300 4.7 (0.1) x 106 1.97E+09 4.78E+12 
Disk 2 6.0 (0.1) x 108 120 5.0 (0.1) x 106 2.40E+09 5.54E+12 
Disk 3 1.13 (0.02) x 109 120 9.4 (0.2) x 106 2.91E+09 7.2E+12 
Disk 4 8.0 (0.2) x 108 120 6.6 (0.1) x 106 3.47E+09 8.94E+12 
Disk 5 1.61 (0.03) x 109 300 5.4 (0.1) x 106 2.29E+09 5.5E+12 
Disk 6 6.5 (0.1) x 108 120 5.4 (0.1) x 106 2.62E+09 6.09E+12 
 
 An aliquot of 1 mL from each of the collections was analyzed by an HPGe detector to 
measure total 67Cu activity using the characteristic gamma rays (91.3, 93.3, 184.6, 300.2, and 
393.5 keV).  It is important to note that 67Ga was present in the secondary beam.  Because 
greater than 99% of the gallium remains bound to the disk and more than 99% of the copper 
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elutes from the disk upon the addition of 6M HCl, the contribution to the above characteristic 
gamma rays from 67Ga could be calculated and used to correct the total 67Cu activity.  These 
results were compared to the amount of 67Cu delivered to the water target station for each 
collection and are listed in Table 5-3.  The average collection efficiency was found to be 115 ± 
18 %.   
Sample Z001I-C (Mbq) Z030F-C (MBq) HPGe (MBq) Collection Efficiency  
Collection 1 1.1 (0.2) 1.2 (0.3)  1.16 (0.03)  101 (15) 
Collection 2 0.8 (0.2)  0.8 (0.2)  0.881 (0.003)  112 (17) 
Collection 3 0.6 (0.1)  0.6 (0.1)  0.799 (0.002) 133 (20) 
 
 
Development of a Chemical Separation Strategy 
 The theoretical beam contaminants delivered to the water cell and their decay products 
were modeled using the LISE++ code with the EPAX3 cross sections and the Nucleonica© 
decay engine, respectively, as was carried out for the previous experiments in Chapters 3 and 4.  
The theoretical contaminants at three days post irradiation are listed in Table 5-4.  The 
separation strategy consists of two parts.  First passing the liquid through a chelation disk 
functionalized with iminodiacetic acid groups.  At pH 5, the carboxylate groups are negatively 
charged, which results in the binding of positively charged metal ions.  Neutral or negatively 
charged species will not bind to the chelation disk and therefore can be separated from the 
isotope of interest 67Cu2+.  The second part consists of using hydrochloric acid to remove the 2+ 
metal ions from the chelation disk.  This is followed by passing the eluent through a column 
containing quaternary amine functionalized anion exchange resin.  At high chloride 
concentrations many metals form negatively charged metal chloride species such as MCl3
- or 
MCl4
2-.  Varying the concentration of chloride allows for separation of the first row transition 
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metals, as each metal forms these negatively charged complexes at different chloride 
concentrations.  As the chloride concentration is lowered, metals exist primarily as cationic 
species and are eluted from the resin.  Preliminary experiments determined that > 99% of the 
titanium, vanadium and manganese would be separated from 67Cu with the chelation disk and the 
first three 6M HCl fractions.  This resulted from the formation of TiO2, H2VO4
-, Mn2+, and 
MnO2
10-12 in aqueous solutions at pH 5.  Iron, existing as Fe2+, was found to elute from the 
column in the 0.5M HCl fraction.  The best separation achieved for cobalt and copper was the 
use of three 6M HCl fractions, which removed ~80% of the cobalt.  Arsenic, in aqueous 
solutions at pH 5, exists both as the neutral compound H3AsO3 and the negatively charged 
complex H2AsO4
-.  These arsenic species were expected to pass through the chelation disk.13  
Therefore, the separation strategy developed for the separation of 67Cu from the aqueous beam 
dump consisted of the use of the chelation disk, followed by anion exchange using three fractions 
of 6M HCl, a 2.5M HCl fraction, and a 0.5M HCl fraction.       
 
Separation of 67Cu from the Secondary Beam Collections 
 Separation of 67Cu was performed as discussed in the methods above.  Figure 5-2 shows 
the separation profile of all the beam contaminants as measured using HPGe analysis of the 
characteristic gamma rays for one or more isotopes of each element.  HPGe spectra were 
obtained immediately after separation.  Additional HPGe spectra taken for longer time intervals 
were obtained after the short-lived isotopes decayed to measure the concentrations of long-lived 
isotopes.  Figure 5-3 shows the HPGe spectra taken for each part of the separation.   
Each gamma ray was assigned to an isotope by using the Lawrence Berkeley National 
Laboratory Radiation Search database.14  In the case where different isotopes had gamma rays 
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that could not be resolved, other gamma rays were used to calculate the activity in order to 
correct for the peak contribution from both radioisotopes.  All radioisotopes measured were 
corrected for decay while counting and results were decay corrected to the end of bombardment.  
The identifying isotopes, theoretical amount of each element with respect to 67Cu, and the final 
contamination to 67Cu ratios are listed in Table 5-4.  The success of the chemistry is measured 
by the ratio of the final contaminant concentration vs the initial contaminant concentration.  
There are many cases where this ratio, the decontamination factor, is so large that no residual 
activity can be measured.  The worst case observed was for cobalt, where the final solution could 
only be decontaminated by a factor of 3.   
 74 ± 4% of the 67Cu was obtained in the 2.5M fractions with a radiochemical purity of 
>99%.  The other contaminants present in the 67Cu fractions measured by HPGe for 12 hours and 
decay corrected to end of bombardment were 58Co (0.07%), 48Sc (0.06%), 47Sc (0.06%), and 
72Ga (0.30%).  No additional radioactive contamination was detected in the 2.5M HCl 67Cu 
fractions.  The 67Cu fraction was brought to dryness by heating followed by reconstitution in 
20μL 0.1M HCl. 
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Table 5-4.  Contaminating elements present in the secondary beam collections at three days post 
bombardment, the isotopes used to follow the separation of each element, and the initial and final 
contaminant to 67Cu ratios. 
Contaminating  
Element 
Identifying  
Isotopes 
Initial Contaminant  
to 67Cu Ratio 
Final Contaminant  
to 67Cu Ratio 
Ge 69Ge 30 Below Detection 
As 74As 24 Below Detection 
Ga 72Ga 5.48 0.1096 
Zn 69MZn 5.48 Below Detection 
Ni 57Ni 3.55 Below Detection 
Fe 59Fe 2.58 Below Detection 
Cu 67Cu 1.87 1.87 
Cr 51Cr 1.13 Below Detection 
K 43K 0.81 Below Detection 
Ca 47Ca 0.81 Below Detection 
V 48V 0.42 Below Detection 
Sc 46Sc, 47Sc, 48Sc 0.39 0.0078 
Mn 52Mn 0.32 Below Detection 
Se 75Se 0.13 Below Detection 
Co 58Co 0.06 0.018 
 
67Cu-NOTA-Bz-Panitumumab Labeling and Biodistribution Studies 
The final concentration of the NOTA conjugated Panitumumab was measured via the 
Bradford assay to be 5.55mg/mL.  The immunoreactivity (measurement of the retained 
functionality of the antibody after conjugating with NOTA) was measured to be 97 ± 2 % and 
the data used to obtain this value is shown graphically in Figure 5-4.  NOTA-Bz-Panitumumab 
was radiolabeled with 67Cu at a final specific activity of 740Bq/μg.   
113 kBq of 740 Bq/μg 67Cu-NOTA-Bz-Panitumumab was injected into three colon 
cancer xenografted mice.  At 5 days post injection the mice were sacrificed and their organs 
assayed for % Injected Dose per gram of tissue.  Biodistribution data for 67Cu-NOTA-Bz-
Panitumumab is shown in Figure 5-5.  The %ID/g of the tumor was found to be 12.5 ± 0.7 %, 
which is in strong agreement with results reported by Chang et al.5   
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Figure 5-4.  The ratio of bound vs total 64Cu-NOTA-Bz-Panitumumab vs. the total amount of 
antibody (pmol).  Immunoreactivity was calculated using method 3 as described by Konishi 
et al.9 
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Figure 5-5.  Biodistribution of 67Cu-NOTA-Bz-Panitumumab in HCT-116 colon cancer 
xenografts.  The %ID/g of the tumor was measured to be 12.5 ± 0.7 %. 
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Discussion 
 Our results show that 67Cu was separable with high radiochemical purity from an aqueous 
beam dump containing many contaminants.  An anti-EGFR antibody, Panitumumab, was 
successfully conjugated with NOTA-Bz-NCS without affecting its antigen binding properties.  
The purified 67Cu was then used to radiolabel the Panitumumab conjugate to obtain a 
biodistribution profile for 67Cu-NOTA-Bz-Panitumumab in HCT-116 colon cancer xenografted 
mice as a proof-of-concept.   
 The effective specific activity of 67Cu-NOTA-Bz-Panitumumab was low (20nCi/μg).  
Since the elements in the secondary beam had one or more isotopes that could be used as a 
radiotracer, and the radiochemical purity of 67Cu was measured to be greater than 99%, it is 
suspected that the lower specific activity did not result from poor separation of the secondary 
beam.  One potential source of stable contamination is the tantalum foil that was used as the 
entrance window to the liquid water target cell.  Other potential sources of contamination are 
from the glassware, vials, or chemicals used in the separation process.  The final 67Cu fraction 
has been shipped to Missouri University Research Reactor (MURR) for elemental analysis using 
inductively coupled plasma mass spectrometry.        
 One limitation of this study was the contaminants present in the beam as they only 
consisted of elements located in period four of the periodic table.  It is estimated that ~60% of 
the primary beams supplied at FRIB will be uranium.  Fragmentation of the uranium beam will 
create waste isotopes of all elements lower in mass than uranium.  The additional contamination 
generated from uranium fragmentation will require additional separation steps and further loss of 
67Cu in the process.  Future research should include the separation efficiency for 67Cu from 
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fission fragments along with decontamination factors for elements between selenium and 
uranium in the periodic table.   
 Another limitation of this study was the exclusion of mixed bed resin as a first step in the 
separation strategy.  At the FRIB facility the aqueous beam dump will be circulated through 
columns containing mixed bed resins as a way to remove the radioactivity from the water.  
Isotopes of interest for applications research will have to be eluted from this resin.  Future 
experiments should be performed using the mixed bed resin that will be employed at FRIB.    
 In conclusion, 67Cu was obtained with high radiochemical purity and the decontamination 
factors for elements from potassium through selenium were determined.  67Cu was acquired in 
the proper chemical form to be used for radiolabeling molecular probes.  These studies support 
the hypothesis that 67Cu can be harvested from the aqueous beam dump at FRIB for use in pre-
clinical research.   
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Chapter 6 
 
Cyclotron production of high specific activity 55Co and the 
evaluation of the stability of 55Co metal-chelate-peptide complexes in 
vivo  
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Introduction 
Recently interest in positron emitting metals has increased due to their longer half-lives 
when compared to traditional PET isotopes such as 18F, 11C, and 15O.  Currently the most 
common radiometals used in PET imaging are 64Cu, 68Ga, 89Zr, and 86Y with 64Cu, 68Ga, and 89Zr 
being used in clinical trials.  The chemistry of each metal is different and chelates need to be 
optimized for the radiometal of interest.  Therefore when developing new positron-emitting 
radiometals for use in pre-clinical research it is important to establish chelators that provide 
stable metal-chelate complexes in vivo. 
55Co is an isotope also of interest for PET imaging.  It has a half-life of 17.5 hr, a positron 
branching ratio of 77%, and an average positron energy of 570 keV (Figure 6-1) qualities that 
make it a candidate for labelling peptides, small molecules, and antibody fragments.1-6  55CoCl2 
has also been used clinically to image ischemia in stroke patients7-10 and in late-onset epileptic 
seizures.11  With the growing interest in 55Co as a PET imaging agent, it is important to study the 
pre-clinical pharmacological properties of this isotope.  Information on the biodistribution of free 
55CoCl2 along with the stability of 
55Co metal-chelate complexes in vivo is required to design 
imaging agents employing this isotope.   
55Co can be made via several nuclear reactions such as 58Ni(p,α)55Co, 56Fe(p,2n)55Co, and 
54Fe(d,n)55Co.12-19  The 54Fe(d,n)55Co has the highest measured cross section at low energies,3,20 
however 54Fe has a low natural abundance and thus this target may be cost-prohibitive for 
routine production in most laboratories.  The 56Fe(p,2n)55Co reaction also creates undesirable  
56Co via the 56Fe(p,n)56Co reaction.  56Co is a positron emitting isotope with a half-life of 77d, 
many high energy photons, and chemically inseparable from 55Co.  The proton reaction on 58Ni 
has a higher cross section at lower energies than the proton reaction on 56Fe16,18,19 making it more 
107 
 
desirable for low-energy (15 MeV) cyclotrons.  This method also produces a small amount of a 
side product, 57Co (t1/2=271.8d).  
57Co decays 100% by electron capture and has a low-energy 
gamma ray of 122 keV.  Therefore the nickel route is a better option for the production of 55Co 
for applications in PET imaging.   
 
The production of 55Co using natNi and 58Ni have been performed,6,17 however only the 
radiochemical purity was reported and specific activity of the final product was not addressed.  
High effective specific activity (ESA) of radiometals is important as metal contaminants have 
negative impacts on radiolabelling,21,22  For best radiolabelling results using 55Co, ESA 
measurements must be performed and productions optimized so that high-specific activity 
material can be obtained.   
In this work, the production of 55Co via the 58Ni(p,α)55Co reaction is discussed along with 
ESA measurements performed using both DOTA titrations and Ion Chromatography.21  An anti-
VEGF peptide previously investigated by our group, L19K-FDNB, has been shown to have a 
long blood clearance time.23  This property makes this peptide an optimal system for studying the 
 
Figure 6-1.  Simplified decay scheme for 55Co. 
- 55Co 17.53 hr
-
55Fe 2.73 y 
EC 23%
β+ 77%
1409 keV
Simplified Decay Scheme
52%
-
36%
931 keV-
477 keV
108 
 
stability of different metal chelate complexes in vivo at time points up to 48 hrs.  The 
biodistribution data for 55CoCl2 and 
55Co-NO2A-L19K-FDNB and 55Co-DO3A-L19K-FDNB 
were compared at 24 and 48 hrs post injection to establish the in vivo stability of 55Co chelated 
with NO2A and DO3A in tumor-bearing mice. 
 
Materials and Methods 
Materials 
Trace metals grade reagents were purchased from Sigma-Aldrich (USA) and used 
without purification and Milli-Q deionized water (18 MΩ cm-1) was used for all dilutions unless 
stated otherwise.  All glassware and vials were acid washed in 8M HNO3 for 24 hrs prior to use.  
DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) was purchased from 
Macrocyclics (USA).  Two versions of the peptide L19K were synthesized by CPC Scientific 
consisting of the sequence Chelate-PEG4-GGNECDIARMWEWECFERK-CONH2, with a Cys-
Cys disulfide bridge and polyethylene glycol (PEG) as a spacer between peptide and chelator 
where the chelators were either NO2A or DO3A.  58Ni was purchased from Isoflex (USA) with 
99.48% isotopic enrichment.    
 
Targetry and Irradiation 
45-55 mg of 58Ni in powder form was plated onto a gold disk by electrodeposition as 
previously described by McCarthy et al.24  The electroplating cell was 9 cm in height with an 
inner diameter of 1.8 cm.  The bottom of the cell consisted of a teflon base that connected to the 
gold disk exposing a 5 mm circle.  A graphite rod was used as the cathode and stirred the 
solution slowly as a voltage of 2.5 V was applied for ~12 hrs.  The current remained between 8-
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20 mA throughout the process.  Targets were irradiated on a 15 MeV cyclotron (CS-15) for 20-
60 μAhrs.  Targets were allowed to sit for two hours prior to processing to allow short-lived 
contaminants to decay.   
 
Purification 
For processing, targets were placed in 10 mL 9 M HCl and heated with reflux for 
approximately one hour in order to dissolve the nickel from the gold disk.  Once the solution 
cooled it was placed in a 1 cm x 10 cm glass column (Biorad, USA) with 2.5 mg AG1-X8 resin 
(Biorad, USA).  In order to determine separation conditions, the eluate along with 10-40 mL of 9 
M HCl were collected followed by another 10 mL of 0.5 M HCl to elute the 55Co.  Fractions of 1 
mL were collected and analyzed using an HPGe (High Purity Germanium) detector (Canberra, 
USA) and the final 55Co fractions were evaporated to dryness and reconstituted with 20 μL Milli-
Q water.  55Co productions were analyzed using Ion Chromatography21 for transition metal 
contaminations.    
 
Effective Specific Activity 
DOTA titrations were performed in order to determine the effective specific activity of 
55Co productions and the method was adapted from the TETA titration method reported 
previously by McCarthy et al.24  1.2 MBq (5 µL) of 55Co was added to eight different 
concentrations of DOTA in ammonium acetate pH 5.5 ranging from 4.3 × 10-4 μmol to 6.3 × 10-2 
μmol. Final volume was brought to 50 µL using 0.5 M ammonium acetate buffer pH 5.5.  The 
solutions were placed in an agitating incubator at 37 ºC for 30 min.  Solutions were cooled to 
room temperature and then centrifuged.  A 1 µL sample from each DOTA concentration along 
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with 1 µL unbound 55Co was analyzed for the percent 55Co incorporated determined by Thin 
Layer Chromatography (TLC) using silica plates and 1:1 mixture of 10% ammonium acetate and 
methanol as an eluent.  Plates were analyzed using a Radio TLC Plate Reader (Bioscan, 
Washington DC).  Data was plotted as molar concentration of DOTA vs. % 55Co incorporation. 
The curve was fit using a sigmoid plot fit program in Prism (Graphpad, USA).  The EC50 value, 
concentration of 55Co that bound to 50% of the DOTA molecules, was determined from this fit. 
The ESA was set equal to two times the EC50 value. 
 
 
Animal Models 
All animal care was performed as stated in the Guide for Care and Use for Laboratory 
Animals by the National Institutes of Health under a protocol approved by the Animal Studies 
Committee at Washington University in St. Louis.  Female Athymic Nu/Nu mice (National 
Cancer Institute, USA) aged 6-9 weeks were anesthetized with a ketamine/xylazine cocktail 
(VEDCO, USA).  100 μL of approximately 2 x 107 cell/mL HCT-116 colon cancer cells 
suspended in saline were subcutaneously injected into the shoulder.  Tumors were allowed to 
grow for two weeks before imaging and biodistribution studies. 
 
Small-Animal PET/CT imaging  
Prior to imaging, animals were anesthetized with 2% isoflurane.  100 μL of 74 kBq/μL 
55CoCl2 in 0.1 N saline was injected into HCT-116 tumor bearing mice (n=4) via tail vein 
injection and imaged using an Inveon MicroPET/CT scanner (Siemens, USA) at 2, 24, and 48 
hrs post injection.  Static PET images were acquired for 20 minutes.  PET data was reconstructed 
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using standard methods with the maximum a posteriori probability (MAP) algorithm and co-
registered with CT (computed tomography) using image display software (Inveon Research 
Workplace Workstation, Siemens, USA).  Volumes of Interest (VOI) were drawn using CT 
anatomical guidelines. 
 
Biodistributions 
100 μL of 74 kBq/μL 55CoCl2, 37 kBq/μL 55Co-NO2A-FDNB, or 37 kBq/μL 55Co-
DO3A-FDNB in 0.1 N saline were injected into HCT-116 tumor bearing mice.  55Co-NO2A-
FDNB and 55Co-DO3A-FDNB were prepared and labeled as the 64Cu analogues described by 
Marquez et al.23 and with a final specific activity of 3.7 MBq/ug.  For each agent, (n=3) mice 
were sacrificed at 24 and 48 hrs post injection followed by removal of blood, lung, liver, spleen, 
kidney, muscle, fat, heart, brain, bone, tumor, stomach, small intestine (sm int), upper large 
intestine (u lg int), and lower large intestine (l lg int).  Each organ was weighed and measured for 
radioactivity using a gamma counter.  The radioactivity was background subtracted, decay 
corrected to time of injection and reported as % ID/g (percent injected dose/g tissue).   
 
Statistical Analysis  
All data were analyzed using Graphpad Prism version 6 (Graphpad, USA).  P values 
were calculated using one-way ANOVA to compare more than two groups with one variable.  P 
values with 95% confidence interval (P < 0.05) were considered significant. 
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Results 
Production and Purification of High Specific Activity 55Co 
58Ni was plated onto a gold disk with an average efficiency of 95 ± 3 % and thickness of 
~300μm.  Irradiations produced an average of 6 ± 1 MBq 55Co/μAh which is consistent with 
yields predicted by Kaufman.19  57Ni and 57Co were coproduced at rates of 16 ± 2 kBq/μAh and 
11 ± 2 kBq/μAh respectively.   
Due to the coproduction of 57Ni, separation could be analyzed by measuring the 
characteristic gamma rays of 57Ni (E1=1.378 MeV, I1=81.7% and E2=0.127 MeV, I2=16.7%) and 
55Co (E1=0.931 MeV, I1=75%; E2=0.477 MeV, I2=20.2% and E3=1.409 MeV, I3=16.9%) in each 
fraction using an HPGe detector.  Elution profiles for 57Ni and 55Co are shown in Figure 6-2.  
57Co contamination was determined by analyzing its characteristic gamma ray 0.122 MeV 
(85.6%) in each fraction.  Washing the column with an additional 10-40 mL 9 M HCl removed 
nickel without significant loss of 55Co.  The average recovery of 55Co with a 40 mL 9 M HCl 
column wash was 92 ± 3 %.  
ESA measured via DOTA titration was found to be 259 MBq/μmol DOTA when washing 
the column with 10 mL 9 M HCl.  Increasing the column wash to 40 mL resulted in an increased 
ESA of 1.96 GBq/μmol DOTA (Figure 6-3).  Ion Chromatography measured nickel 
concentrations to be 3.5 μmol/μCi and 28 nmol/μCi for 10 mL and 40 mL column washes 
respectively.  The only radioactive impurity found in the final 55Co fraction was 57Co at 0.2 % of 
the total 55Co activity.    
113 
 
 
 
 
 
Figure 6-2.  Concentration of 55Co and 57Ni in each fraction, as measured using HPGe 
detection of the characteristic gamma rays, showing good separation. 
 
Figure 6-3.  55Co-DOTA titration curves demonstrating a seven-fold increase in ESA (259 
MBq/μmol to 1.96 GBq/μmol) when washing the column with an additional 40 mL 9 M HCl 
acid versus a 10 mL column wash. 
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55CoCl2 Small-Animal PET/CT Imaging and Biodistribution 
As an emerging radioisotope, in vivo stability data of different 55Co-chelate complexes 
had not been previously measured.  In order to determine the in vivo stability of these chelates it 
is important to know where free 55Co accumulates in tumor models.  The distribution of free 
55Co had not been investigated in tumor xenograft models to our knowledge.  HCT-116 tumor 
xenografts were imaged (Figure 6-4A) and post PET biodistributions (Table 1) were performed 
at 2, 24, and 48 hrs p. i. (post injection) to investigate the distribution of free 55Co in this model.  
Interestingly, significant accretion of 55Co occurred in the tumor at each of these time points.  
Tumor-to-blood ratios (Figure 6-4B) increased over time, likely due to clearance from the blood 
occurring at a higher rate than washout from the tumor implying that 55Co is being retained in the 
tumor cells.  Tumor-to-blood ratios at 2 and 48 hrs were 0.6 ± 0.1 and 1.9 ± 0.4 respectively 
exhibiting a 3-fold increase (P=0.006).  High uptake in the heart could be due to the potential of 
Co2+ to mimic calcium influx.7,10  Clearance of free 55Co occurred through the liver and kidney 
as established by the high values listed in Table 1.   
Table 1.  55CoCl2 Biodistribution Data at 2, 24, and 48 hrs p. i. 
Organ 2 hr (%ID/g) 24 hr (%ID/g) 48 hr (%ID/g) 
Blood 4.5 ± 0.6 1.40 ± 0.04 0.46 ± 0.05 
Lung 4.0 ± 0.3 1.9 ± 0.1 0.98 ± 0.09 
Liver(all) 15.7 ± 0.4 6.2 ± 0.8 2.7 ± 0.7 
Spleen 1.9 ± 0.4 0.82 ± 0.05 0.46 ± 0.04 
Kidney 10.5 ± 1.4 4.4 ± 0.4 1.9 ± 0.2 
Muscle 0.6 ± 0.1 0.37 ± 0.08 0.17 ± 0.03 
Fat 1.5 ± 0.9 0.7 ± 0.4 0.23 ± 0.05 
Heart 4.8 ± 0.4 2.8 ± 0.7 1.4 ± 0.2 
Brain 0.31 ± 0.02 0.17 ± 0.03 0.11 ± 0.01 
Bone 1.3 ± 0.2 0.8 ± 0.1 0.5 ± 0.1 
Tumor 2.8 ± 0.6 1.6 ± 0.2 0.86 ± 0.08 
Stomach 1.1 ± 0.1 1.0 ± 0.2 0.5 ± 0.1 
Sm int 3.6 ± 0.6 1.1 ± 0.2 0.50 ± 0.04 
U lg int 4.3 ± 0.8 1.5 ± 0.1 0.7 ± 0.1 
L lg int 1.9 ± 1.0 2.2 ± 0.3 1.2 ± 0.2 
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Stability of 55Co-Chelate Complexes 
The stability of radiometal-chelate combinations is crucial when designing new PET 
imaging probes.  Complexes that are not stable in vivo can lead to the radiometal decomplexing 
from the chelate and accumulating in different organs throughout the body increasing 
background signal and dose to non-target organs.  It has previously been established that 
changing the radiometal on peptides can have a drastic effect on the affinity of the peptide to its 
receptor.25  Using 55Co to radiolabel L19K-FDNB dramatically decreased the affinity for VEGF 
when compared to labelling with 64Cu.23  This decreased affinity and long blood clearance time 
presents an optimal model to examine the in vivo stability of 55Co-chelate complexes.   
The 24 and 48 hr biodistributions of 55Co-NO2A-L19K-FDNB and 55Co-DO3A-L19K-
FDNB were compared to the biodistribution of free 55Co (Figure 6-5).  These data show that 
 
Figure 6-4. 24 and 48 hr PET images of 55CoCl2 showing uptake in the tumor and clearance 
through the liver, kidney, and intestines (A).  Tumor-to-blood ratio exhibits a 3-fold increase 
from 2-48 hrs (B). 
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both NO2A and DO3A chelates radiolabeled with 55Co exhibit good in vivo stability.  This is 
ascertained by the low uptake of activity in the liver, lung, heart, bone, stomach, and small 
intestine when compared to high uptake of free 55Co in these organs.  The difference in uptake is 
most notable in the liver (6-fold decrease at 24 and 48 hrs) and the heart (4-fold decrease at 24 
hrs and 7-fold decrease at 48 hrs).   
 
 
 
 
 
 
 
Figure 6-5.  Comparison of the 24 hr (A) and 48 hr (B) biodistributions of 55CoCl2 with 
55Co-
NO2A-FDNB and 55Co-DO3A-FDNB exhibiting the in vivo stability of 55Co-NO2A and 
55Co-DO3A complexes. 
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Discussion 
The 58Ni(p,α)55Co reaction is an effective route for producing high specific activity 55Co.  
Previously this method was reported using a copper disk17 as opposed to gold, however using 
copper as the target backing material could have a negative effect on effective specific activity as 
copper has a high affinity to both NOTA and DOTA chelators and would compete with 55Co for 
binding.  The downside to this reaction is that it has a lower cross section when compared to 
other radiometals such as 64Cu and 89Zr, which may limit the availability of this isotope to 
facilities that have solid target cyclotron capabilities.   
The biodistribution of 55CoCl2 is comparable to those seen for 
64CuCl2.
26-30  The uptake in 
the tumor of 55Co is of interest and should be evaluated further.  It is possible that its uptake is 
due to the over expression of calcium ion channels often found in cancer cells.  As discussed 
earlier several studies have shown uptake of 55CoCl2 in ischemic cells and is believed to be due 
to 55Co partially mirroring calcium influx.7,10   
The in vivo stability of the NOTA and DOTA analogs, NO2A and NO3A, complexed 
with 55Co provides the foundation for developing 55Co labeled peptides, antibodies, nanoparticles 
and small molecules.  55Co-NOTA and 55Co-DOTA complexes demonstrate greater stability in 
vivo than 64Cu-NOTA and 64Cu-DOTA complexes which could be beneficial in cases where 
reduced background signal is desired i.e. liver metastases.  Additionally the high positron 
branching ratio (4 times that of 64Cu and 3 times that of 89Zr) leads to similar images with a 
lower amount of radioactivity administered.   
Since the affinity of some peptides is dependent on the attached radiometal it would be of 
interest to examine this effect on different peptide models.  The anti-VEGF peptide used in this 
work exhibited lower affinity than previously measured with 64Cu, however in work done by 
118 
 
Heppler et al.2 55Co-DOTATOC showed the highest affinity for the somatostatin type two 
receptor than any other radiometal measured.  Further research as to the structure activity 
relationship of these peptide-chelate-metal complexes would be significant for designing 
superior PET imaging probes.    
 
Conclusions 
55Co can be made with high specific activity via the 58Ni(p,α)55Co reaction.  The in vivo 
stability of 55Co labeled NOTA and DOTA derivatives make this radioisotope a promising 
isotope for many different applications.  Future work should compare the affinity of 55Co labeled 
peptides with other radiometals to optimize the best metal-chelate-peptide combination for the 
application.            
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7.1 Radioisotopes in Medicine 
 Mother Nature provides us with several radioisotopes that are used for a broad range of 
disciplines.  In addition to these naturally occurring radioisotopes, many radioisotopes are made 
synthetically using cyclotrons, linear accelerators, or nuclear reactors.  Medical research employs 
almost exclusively synthetic radioisotopes for use in basic science research, imaging, and 
therapy.   
 From 2006 to 2010 the number of nuclear medicine procedures performed annually 
worldwide increased from 18 million to well over 30 million.1,2  The growth of nuclear medicine 
has sparked an increase in the developments of advanced imaging and therapeutic agents and 
more radioisotopes are being used than ever before.3  The desire for different chemistries is 
driving the increased demand for radioisotopes of elements not previously used for nuclear 
imaging and therapy.  The distinctive chemistries and the broad range of nuclear properties of the 
many radioisotopes located near the line of beta-stability make for a large playing field of 
potential medical isotopes.     
 In Figure 7-1 the current sources of medical radioisotopes are shown; however, some 
desired radioisotopes cannot easily be made by current methods.  One such isotope is 67Cu, a 
radioisotope of interest for cancer therapy.4,5  To make usable quantities of 67Cu a new method, 
isotope harvesting, is being investigated.  The majority of the work in this thesis investigates the 
feasibility of harvesting 67Cu from an aqueous beam dump at a new national facility. 
 
Figure 7-1.  Examples of medical radioisotopes from different sources. 
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7.2 Isotope Harvesting Conclusions 
 The first step in determining the feasibility of isotope harvesting was the successful 
design and implementation of an end station that could serve as a mock beam dump.  This end 
station was constructed and proved to be functional by several collections of 24Na from the water 
exposed to an analyzed 24Na beam.  The end station proved to be very robust showing very little 
radioactive damage from the secondary ion beam.   
 With this first successful use of the end station, we moved on to an isotope of interest to 
medicine, 67Cu.  An analyzed 67Cu secondary beam was collected in the water target cell and 
followed with the chemical separation of 67Cu.  Chemical separations gave an average recovery 
of 88 ± 3 % for 67Cu which was in strong agreement with results obtained from preliminary 
separation experiments performed prior to the experiment.  The final 67Cu product was 
successfully used to radiolabel an anti-HER2 antibody Trastuzumab (Herceptin), which 
established that the 67Cu obtained from the aqueous beam dump was both in the correct chemical 
form and appropriate effective specific activity.   
 The analyzed 67Cu secondary beam was an idealized case.  To better demonstrate the 
feasibility of isotope harvesting, collection and separation of 67Cu from an unanalyzed (i.e. 
mixed) beam was performed.  This collection contained many contaminants, both radioactive 
and stable.  A separation strategy was designed and implemented and exhibited an average 
recovery of 74 ± 4 % for 67Cu with a radiochemical purity of >99%.  The resulting 67Cu was used 
to radiolabel an anti-EGFR antibody, Panitumumab, and injected into colon cancer xenografted 
mice.  The tumor uptake of the 67Cu-NOTA-bz-Panitumumab was comparable to that observed 
previously by Chang et al.6   
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The final specific activity was 20 nCi/μg which is lower than normally observed with 
commonly available radioisotopes such as 89Zr and 64Cu.  This low specific activity was likely 
due to stable metal contaminants as the final 67Cu fraction had high radiochemical purity.  The 
decontamination factors and the theoretical ratio of the different elements to 67Cu present in the 
beam (Table 5-4) suggest that the low specific activity did not result from poor separation of the 
beam fragments.  The stable metal contamination was most likely introduced to the 67Cu fraction 
during the separation processes by some unknown source.  Inductively coupled plasma mass 
spectrometry analysis of the final fraction will better determine the composition of the 
contamination and a method will be developed to eliminate this contamination in future 
experiments.   
 
7.3 Future Work 
Although we were able to separate 67Cu from a fragmented 76Ge beam with high 
radiochemical purity, there is still more work to be done before the true feasibility of harvesting 
this radioisotope can be determined.  The first challenge to be addressed is the separation of 67Cu 
from a fragmented uranium beam.  It is estimated that 60% of the primary beams used at the 
Facility for Rare Isotope Beams will be uranium, which will require a more complicated 
chemical separation scheme to achieve good radiochemical purity and effective specific activity.  
The second challenge is the use of mixed bed resin.  The aqueous beam dump at FRIB will 
constantly be circulated through a column of mixed bed resin.  Experiments should be performed 
to observe the amount of 67Cu that binds to this resin along with determining an elution protocol.  
Modifications are currently in progress to continuously circulate the water in the target cell 
through a column of mixed bed resin.   
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Experiments exploring the potential of harvesting other radioisotopes of interest would 
also be essential for the evaluation of the feasibility of isotope harvesting from FRIB.  To make 
isotope harvesting a reality, examples of successful separations of several different radioisotopes 
of interest to a variety of fields should be provided.  A proposal to collect secondary beams 
containing 48V and 85Kr at the NSCL has been accepted and the experiments are likely to start 
sometime next year.  The harvesting of 67Cu from the aqueous beam dump, as described herein, 
can serve as a scaffold from which separation strategies for the above radioisotopes in addition to 
those listed in Table 1-2 can be built. 
In conclusion, the work presented here provides a strong foundation for the harvesting of 
67Cu from a heavy-ion fragmentation facility.  Radioisotope users from different fields would 
benefit from isotope harvesting at the future FRIB facility.  While much more work still needs to 
be performed for 67Cu and each radioisotope will present its own challenges, isotope harvesting 
appears to be a promising pathway to radioisotopes that are not currently available in usable 
quantities by conventional methods.   
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Glossary of Terms 
 
Antibody:  An antibody is a protein produced by the body's immune system against an antigens. 
Antigen:   A foreign substance that, when introduced into the body, is capable of stimulating an 
immune response. 
Becquerel (Bq):  Unit to measure radioactivity.  1Bq = 1disintegration/second 
Catabolism:  The set of metabolic pathways that breaks down molecules into smaller units to 
release energy. 
Curie (Ci):  Unit to measure radioactivity.  1Ci = 3.7x1010Bq (d/s) 
DOTA:  1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid 
EC50:   The concentration of a drug that gives half-maximal response.  
Effective Specific Activity:  The amount of radioactivity per unit mass of competing metal for a 
certain chemical or biological reaction. 
High-Performance Liquid Chromatography (HPLC):  A high pressure system which employs 
a column and solvents to separate components of a solution. 
Immunoreactivity:  Measurement of the retained functionality of the antibody after conjugating 
with a chelator. 
Inductively-Coupled Plasma Mass Spectrometry (ICP-MS):  A mass spectrometer that is 
commonly used in elemental analysis. 
Ion Chromatography (IC):  An high-performance liquid chromatography method to separate 
several different first-row transition metals. 
Magnetic Rigidity:  The momentum per unit charge of a particle (p/q).  The units of magnetic 
rigidity are Tm (tesla meters). 
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NOTA:  1,4,7-triazacyclononane-N,N',N"-triacetic acid 
Particle nanoamps (pnA):  Number of particles per nanoamp of beam (pnA is equal to nA for 
H+ or H- beams) 
PIXE:  Particle Induced X-ray Emmission, a method used in elemental analysis. 
TETA:  1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetraacetic acid 
Theoretical (Maximum) Specific Activity:  The amount of radioactivity per μmol of the 
radioactive species (e.g. activity of 64Cu per μmol 64Cu). 
True Specific Activity:  The amount of radioactivity per μmol of atoms of the same element 
(e.g. activity of 64Cu per μmol copper). 
Xenografts:  Cells from one species transplanted into an organism of another species (i.e. human 
cells into mice).   
